Profiles

Keywords
Last Name
Institution

Christopher Goetz

TitleProfessor
InstitutionRush University, Rush Medical College
DepartmentNeurological Sciences, Section of Parkinson's Disease and Movement Disorders
AddressChicago IL 60612
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 36063561200.
    My NIH COMMONS name is CGOETZ.


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Luo S, Liu Y, Teresi JA, Stebbins GT, Goetz CG. Differential item functioning in the Unified Dyskinesia Rating Scale (UDysRS). Mov Disord. 2017 Jun 01. PMID: 28568607.
      View in: PubMed
    2. Goetz CG. Rev Neurol (Paris). 2017 May 10. PMID: 28501142.
      View in: PubMed
    3. Mestre TA, van Duijn E, Davis AM, Bachoud-Lévi AC, Busse M, Anderson KE, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P. Response to letter by Saenz-Farret et al. on "Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations". Mov Disord. 2017 Mar; 32(3):482. PMID: 28256103.
      View in: PubMed
    4. Martino D, Pringsheim TM, Cavanna AE, Colosimo C, Hartmann A, Leckman JF, Luo S, Munchau A, Goetz CG, Stebbins GT, Martinez-Martin P. Systematic review of severity scales and screening instruments for tics: Critique and recommendations. Mov Disord. 2017 Mar; 32(3):467-473. PMID: 28071825.
      View in: PubMed
    5. Kordower JH, Goetz CG, Chu Y, Halliday GM, Nicholson DA, Musial TF, Marmion DJ, Stoessl AJ, Sossi V, Freeman TB, Olanow CW. Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient. Ann Neurol. 2017 Jan; 81(1):46-57. PMID: 27900791.
      View in: PubMed
    6. Pal GD, Ouyang B, Serrano G, Shill HA, Goetz C, Stebbins G, Metman LV, Driver-Dunckley E, Mehta SH, Caviness JN, Sabbagh MN, Adler CH, Beach TG. Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation. Mov Disord. 2017 Feb; 32(2):274-277. PMID: 27911008.
      View in: PubMed
    7. Goetz CG, Liu Y, Stebbins GT, Wang L, Tilley BC, Teresi JA, Merkitch D, Luo S. Gender-, age-, and race/ethnicity-based differential item functioning analysis of the movement disorder society-sponsored revision of the Unified Parkinson's disease rating scale. Mov Disord. 2016 Dec; 31(12):1865-1873. PMID: 27943473.
      View in: PubMed
    8. Mestre TA, van Duijn E, Davis AM, Bachoud-Lévi AC, Busse M, Anderson KE, Ferreira JJ, Mahlknecht P, Tumas V, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P. Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations. Mov Disord. 2016 Oct; 31(10):1466-1478. PMID: 27296904.
      View in: PubMed
    9. Shulman LM, Armstrong M, Ellis T, Gruber-Baldini A, Horak F, Nieuwboer A, Parashos S, Post B, Rogers M, Siderowf A, Goetz CG, Schrag A, Stebbins GT, Martinez-Martin P. Disability Rating Scales in Parkinson's Disease: Critique and Recommendations. Mov Disord. 2016 Oct; 31(10):1455-1465. PMID: 27193358.
      View in: PubMed
    10. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. Abolishing the 1-year rule: How much evidence will be enough? Mov Disord. 2016 Nov; 31(11):1623-1627. PMID: 27666574.
      View in: PubMed
    11. Tison F, Keywood C, Wakefield M, Durif F, Corvol JC, Eggert K, Lew M, Isaacson S, Bezard E, Poli SM, Goetz CG, Trenkwalder C, Rascol O. A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease. Mov Disord. 2016 Sep; 31(9):1373-80. PMID: 27214664.
      View in: PubMed
    12. Postuma RB, Berg D, Adler CH, Bloem BR, Chan P, Deuschl G, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Oertel W, Olanow CW, Poewe W, Stern M. The new definition and diagnostic criteria of Parkinson's disease. Lancet Neurol. 2016 May; 15(6):546-8. PMID: 27302120.
      View in: PubMed
    13. Comella CL, Perlmutter JS, Jinnah HA, Waliczek TA, Rosen AR, Galpern WR, Adler CA, Barbano RL, Factor SA, Goetz CG, Jankovic J, Reich SG, Rodriguez RL, Severt WL, Zurowski M, Fox SH, Stebbins GT. Clinimetric testing of the comprehensive cervical dystonia rating scale. Mov Disord. 2016 Apr; 31(4):563-9. PMID: 26971359; PMCID: PMC4833533 [Available on 04/01/17].
    14. Bloem BR, Marinus J, Almeida Q, Dibble L, Nieuwboer A, Post B, Ruzicka E, Goetz C, Stebbins G, Martinez-Martin P, Schrag A. Measurement instruments to assess posture, gait, and balance in Parkinson's disease: Critique and recommendations. Mov Disord. 2016 Sep; 31(9):1342-55. PMID: 26945525.
      View in: PubMed
    15. Kluger BM, Herlofson K, Chou KL, Lou JS, Goetz CG, Lang AE, Weintraub D, Friedman J. Parkinson's disease-related fatigue: A case definition and recommendations for clinical research. Mov Disord. 2016 May; 31(5):625-31. PMID: 26879133; PMCID: PMC4863238 [Available on 05/01/17].
    16. Pal GD, Hall D, Ouyang B, Phelps J, Alcalay R, Pauciulo MW, Nichols WC, Clark L, Mejia-Santana H, Blasucci L, Goetz CG, Comella C, Colcher A, Gan-Or Z, Rouleau GA, Marder K. Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson's Disease. Mov Disord Clin Pract. 2016 Sep-Oct; 3(5):465-471. PMID: 27709117.
      View in: PubMed
    17. Friedman JH, Beck JC, Chou KL, Clark G, Fagundes CP, Goetz CG, Herlofson K, Kluger B, Krupp LB, Lang AE, Lou JS, Marsh L, Newbould A, Weintraub D. Fatigue in Parkinson's disease: report from a mutidisciplinary symposium. NPJ Parkinsons Dis. 2016; 2. PMID: 27239558.
      View in: PubMed
    18. Goetz CG. Charcot, hysteria, and simulated disorders. Handb Clin Neurol. 2016; 139:11-23. PMID: 27719832.
      View in: PubMed
    19. Diederich NJ, Goldman JG, Stebbins GT, Goetz CG. Failing as doorman and disc jockey at the same time: Amygdalar dysfunction in Parkinson's disease. Mov Disord. 2016 Jan; 31(1):11-22. PMID: 26650182.
      View in: PubMed
    20. Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G. MDS research criteria for prodromal Parkinson's disease. Mov Disord. 2015 Oct; 30(12):1600-11. PMID: 26474317.
      View in: PubMed
    21. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015 Oct; 30(12):1591-601. PMID: 26474316.
      View in: PubMed
    22. Poewe W, Goetz CG. Preface. Mov Disord. 2015 Sep 15; 30(11):1441. PMID: 26301896.
      View in: PubMed
    23. Warren Olanow C, Bartus RT, Baumann TL, Factor S, Boulis N, Stacy M, Turner DA, Marks W, Larson P, Starr PA, Jankovic J, Simpson R, Watts R, Guthrie B, Poston K, Henderson JM, Stern M, Baltuch G, Goetz CG, Herzog C, Kordower JH, Alterman R, Lozano AM, Lang AE. Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. Ann Neurol. 2015 Aug; 78(2):248-57. PMID: 26061140.
      View in: PubMed
    24. Suchorska B, Kunz M, Schniepp R, Jahn K, Goetz C, Tonn JC, Peraud A. Optimized surgical treatment for normal pressure hydrocephalus: comparison between gravitational and differential pressure valves. Acta Neurochir (Wien). 2015 Apr; 157(4):703-9. PMID: 25666108.
      View in: PubMed
    25. Goetz CG, Luo S, Wang L, Tilley BC, LaPelle NR, Stebbins GT. Handling missing values in the MDS-UPDRS. Mov Disord. 2015 Oct; 30(12):1632-8. PMID: 25649812.
      View in: PubMed
    26. Goetz CG, Pal G. Initial management of Parkinson's disease. BMJ. 2014 Dec 19; 349:g6258. PMID: 25527341.
      View in: PubMed
    27. Goldman JG, Holden S, Ouyang B, Bernard B, Goetz CG, Stebbins GT. Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests? Mov Disord. 2015 Mar; 30(3):402-6. PMID: 25449653; PMCID: PMC4357536.
    28. Kashihara K, Kondo T, Mizuno Y, Kikuchi S, Kuno S, Hasegawa K, Hattori N, Mochizuki H, Mori H, Murata M, Nomoto M, Takahashi R, Takeda A, Tsuboi Y, Ugawa Y, Yamanmoto M, Yokochi F, Yoshii F, Stebbins GT, Tilley BC, Luo S, Wang L, LaPelle NR, Goetz CG. Official Japanese Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale: validation against the original English version. Mov Disord Clin Pract. 2014 Sep 01; 1(3):200-212. PMID: 25328906.
      View in: PubMed
    29. Goldman JG, Stebbins GT, Leung V, Tilley BC, Goetz CG. Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS. Parkinsonism Relat Disord. 2014 Nov; 20(11):1135-9. PMID: 25150770; PMCID: PMC4252982.
    30. Cubo E, Goetz CG, Stebbins GT, LaPelle NR, Tilley BC, Wang L, Luo S. Independent Spanish Validation of the Unified Dyskinesia Rating Scale. Mov Disord Clin Pract. 2014 Sep; 1(3):213-218. PMID: 27891530.
      View in: PubMed
    31. Goetz CG, Bergen DC. Maynard M. Cohen, MD, PhD (1920-2014). Neurology. 2014 Jun 03; 82(22):1944-5. PMID: 25013889.
      View in: PubMed
    32. Achey M, Aldred JL, Aljehani N, Bloem BR, Biglan KM, Chan P, Cubo E, Dorsey ER, Goetz CG, Guttman M, Hassan A, Khandhar SM, Mari Z, Spindler M, Tanner CM, van den Haak P, Walker R, Wilkinson JR. The past, present, and future of telemedicine for Parkinson's disease. Mov Disord. 2014 Jun; 29(7):871-83. PMID: 24838316.
      View in: PubMed
    33. Goetz CG, Stebbins GT, Wang L, LaPelle NR, Luo S, Tilley BC. IPMDS-Sponsored Scale Translation Program: Process, Format, and Clinimetric Testing Plan for the MDS-UPDRS and UDysRS. Mov Disord Clin Pract. 2014 Jun; 1(2):97-101. PMID: 27747259.
      View in: PubMed
    34. Barton BR, Bernard B, Czernecki V, Goldman JG, Stebbins G, Dubois B, Goetz CG. Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing. Mov Disord. 2014 Sep; 29(10):1252-7. PMID: 24821679.
      View in: PubMed
    35. Diederich NJ, Stebbins G, Schiltz C, Goetz CG. Are patients with Parkinson's disease blind to blindsight? Brain. 2014 Jun; 137(Pt 6):1838-49. PMID: 24764573; PMCID: PMC4032103.
    36. Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord. 2014 Apr; 29(4):454-62. PMID: 24619848; PMCID: PMC4204150.
    37. Tanner CM, Meng CC, Ravina B, Lang A, Kurlan R, Marek K, Oakes D, Seibyl J, Flagg E, Gauger L, Guest DD, Goetz CG, Kieburtz K, DiEuliis D, Fahn S, Elliott RA, Shoulson I. A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study. Mov Disord. 2014 May; 29(6):743-9. PMID: 24515275.
      View in: PubMed
    38. Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. JAMA Neurol. 2014 Feb; 71(2):141-50. PMID: 24366103; PMCID: PMC3940333.
    39. Goldman JG, Stebbins GT, Dinh V, Bernard B, Merkitch D, deToledo-Morrell L, Goetz CG. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations. Brain. 2014 Mar; 137(Pt 3):849-59. PMID: 24480486; PMCID: PMC3983409.
    40. Martínez-Martín P, Rodríguez-Blázquez C, Forjaz MJ, Alvarez-Sánchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martínez-Castrillo JC, Mendoza-Rodríguez A, Moore HP, Rodríguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG. Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients. Eur J Neurol. 2014 Mar; 21(3):519-24. PMID: 24447695.
      View in: PubMed
    41. Tilley BC, LaPelle NR, Goetz CG, Stebbins GT. Using cognitive pretesting in scale development for Parkinson's disease: the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) example. J Parkinsons Dis. 2014; 4(3):395-404. PMID: 24613868.
      View in: PubMed
    42. Pedroso JL, Barsottini OG, Goetz CG. Babinski's contributions to cerebellar symptomatology: building the basis of the neurological examination. Arq Neuropsiquiatr. 2013 Dec; 71(12):973-5. PMID: 24347019.
      View in: PubMed
    43. Goldman JG, Holden S, Bernard B, Ouyang B, Goetz CG, Stebbins GT. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease. Mov Disord. 2013 Dec; 28(14):1972-9. PMID: 24123267; PMCID: PMC4164432.
    44. Lang AE, Eberly S, Goetz CG, Stebbins G, Oakes D, Marek K, Ravina B, Tanner CM, Shoulson I. Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments. Mov Disord. 2013 Dec; 28(14):1980-6. PMID: 24123383.
      View in: PubMed
    45. Pulliam CL, Eichenseer SR, Goetz CG, Waln O, Hunter CB, Jankovic J, Vaillancourt DE, Giuffrida JP, Heldman DA. Continuous in-home monitoring of essential tremor. Parkinsonism Relat Disord. 2014 Jan; 20(1):37-40. PMID: 24126021; PMCID: PMC3946846.
    46. Elble R, Bain P, Forjaz MJ, Haubenberger D, Testa C, Goetz CG, Leentjens AF, Martinez-Martin P, Pavy-Le Traon A, Post B, Sampaio C, Stebbins GT, Weintraub D, Schrag A. Task force report: scales for screening and evaluating tremor: critique and recommendations. Mov Disord. 2013 Nov; 28(13):1793-800. PMID: 24038576.
      View in: PubMed
    47. Dodel R, Jönsson B, Reese JP, Winter Y, Martinez-Martin P, Holloway R, Sampaio C, Ružicka E, Hawthorne G, Oertel W, Poewe W, Stebbins G, Rascol O, Goetz CG, Schrag A. Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease. Mov Disord. 2014 Feb; 29(2):169-76. PMID: 23861335.
      View in: PubMed
    48. Goetz CG, Vaughan CL, Goldman JG, Stebbins GT. I finally see what you see: Parkinson's disease visual hallucinations captured with functional neuroimaging. Mov Disord. 2014 Jan; 29(1):115-7. PMID: 23843193.
      View in: PubMed
    49. Rodriguez-Blazquez C, Rojo-Abuin JM, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG, Martinez-Martin P. The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease. Parkinsonism Relat Disord. 2013 Oct; 19(10):889-93. PMID: 23791519.
      View in: PubMed
    50. Albanese A, Sorbo FD, Comella C, Jinnah HA, Mink JW, Post B, Vidailhet M, Volkmann J, Warner TT, Leentjens AF, Martinez-Martin P, Stebbins GT, Goetz CG, Schrag A. Dystonia rating scales: critique and recommendations. Mov Disord. 2013 Jun 15; 28(7):874-83. PMID: 23893443; PMCID: PMC4207366.
    51. Pal G, Goetz CG. Assessing bradykinesia in parkinsonian disorders. Front Neurol. 2013; 4:54. PMID: 23760683; PMCID: PMC3669893.
    52. Goldman JG, Ghode RA, Ouyang B, Bernard B, Goetz CG, Stebbins GT. Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease. Parkinsonism Relat Disord. 2013 Sep; 19(9):806-11. PMID: 23735187; PMCID: PMC3729741.
    53. Prodoehl J, Li H, Planetta PJ, Goetz CG, Shannon KM, Tangonan R, Comella CL, Simuni T, Zhou XJ, Leurgans S, Corcos DM, Vaillancourt DE. Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor. Mov Disord. 2013 Nov; 28(13):1816-22. PMID: 23674400; PMCID: PMC3748146.
    54. Goetz CG, Harter DH. Treating melancholia at home: theoretical wisdom and grim reality in the career of E.C. Seguin. Neurology. 2013 Apr 30; 80(18):1710-4. PMID: 23628930; PMCID: PMC3716472.
    55. Martinez-Martin P, Chaudhuri KR, Rojo-Abuin JM, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG. Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. Eur J Neurol. 2015 Jan; 22(1):37-43. PMID: 23607783.
      View in: PubMed
    56. Goetz CG. The Parkinson's disease multidisciplinary package. Mov Disord. 2013 May; 28(5):565. PMID: 23483614.
      View in: PubMed
    57. Neely KA, Planetta PJ, Prodoehl J, Corcos DM, Comella CL, Goetz CG, Shannon KL, Vaillancourt DE. Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy. PLoS One. 2013; 8(3):e58403. PMID: 23505500; PMCID: PMC3594313.
    58. Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale. Mov Disord. 2013 May; 28(5):668-70. PMID: 23408503.
      View in: PubMed
    59. Goetz CG, Stebbins GT, Chung KA, Hauser RA, Miyasaki JM, Nicholas AP, Poewe W, Seppi K, Rascol O, Stacy MA, Nutt JG, Tanner CM, Urkowitz A, Jaglin JA, Ge S. Which dyskinesia scale best detects treatment response? Mov Disord. 2013 Mar; 28(3):341-6. PMID: 23390076.
      View in: PubMed
    60. Goetz CG, Stebbins GT, Tilley BC. Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores. Mov Disord. 2012 Sep 01; 27(10):1239-42. PMID: 22886777.
      View in: PubMed
    61. Martinez-Martin P, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). J Neurol. 2013 Jan; 260(1):228-36. PMID: 22865238.
      View in: PubMed
    62. Goldman JG, Weis H, Stebbins G, Bernard B, Goetz CG. Clinical differences among mild cognitive impairment subtypes in Parkinson's disease. Mov Disord. 2012 Aug; 27(9):1129-36. PMID: 22778009; PMCID: PMC3412930.
    63. Galpern WR, Corrigan-Curay J, Lang AE, Kahn J, Tagle D, Barker RA, Freeman TB, Goetz CG, Kieburtz K, Kim SY, Piantadosi S, Comstock Rick A, Federoff HJ. Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations. Lancet Neurol. 2012 Jul; 11(7):643-50. PMID: 22710757.
      View in: PubMed
    64. Antonini A, Abbruzzese G, Ferini-Strambi L, Tilley B, Huang J, Stebbins GT, Goetz CG, Barone P. Validation of the Italian version of the Movement Disorder Society--Unified Parkinson's Disease Rating Scale. Neurol Sci. 2013 May; 34(5):683-7. PMID: 22678179.
      View in: PubMed
    65. Corcos DM, Comella CL, Goetz CG. Tai chi for patients with Parkinson's disease. N Engl J Med. 2012 May 03; 366(18):1737-8; author reply 1738. PMID: 22551137.
      View in: PubMed
    66. Goldman JG, Stebbins GT, Bernard B, Stoub TR, Goetz CG, deToledo-Morrell L. Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia. Mov Disord. 2012 May; 27(6):727-34. PMID: 22410753; PMCID: PMC3366041.
    67. Kapur SS, Stebbins GT, Goetz CG. Vibration therapy for Parkinson's disease: Charcot's studies revisited. J Parkinsons Dis. 2012; 2(1):23-7. PMID: 23939405.
      View in: PubMed
    68. Barton B, Grabli D, Bernard B, Czernecki V, Goldman JG, Stebbins G, Dubois B, Goetz CG. Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia. Mov Disord. 2012 Feb; 27(2):248-53. PMID: 22162144.
      View in: PubMed
    69. Goetz CG, Tilley BC, Stebbins GT. Dopamine dysregulation syndrome item from the MDS-UPDRS. Mov Disord. 2012 Jan; 27(1):166. PMID: 22025291.
      View in: PubMed
    70. Seidel SE, Tilley BC, Huang P, Palesch YY, Bergmann KJ, Goetz CG, Swearingen CJ. Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale. Parkinsonism Relat Disord. 2012 Mar; 18(3):230-3. PMID: 22018910; PMCID: PMC3288816.
    71. Fox SH, Katzenschlager R, Lim SY, Ravina B, Seppi K, Coelho M, Poewe W, Rascol O, Goetz CG, Sampaio C. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease. Mov Disord. 2011 Oct; 26 Suppl 3:S2-41. PMID: 22021173.
      View in: PubMed
    72. Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG, Sampaio C. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease. Mov Disord. 2011 Oct; 26 Suppl 3:S42-80. PMID: 22021174; PMCID: PMC4020145.
    73. Goetz CG, Stebbins GT, Theeuwes A, Stocchi F, Ferreira JJ, van de Witte S, Bronzova J. Temporal stability of the Unified Dyskinesia Rating Scale. Mov Disord. 2011 Dec; 26(14):2556-9. PMID: 21915907.
      View in: PubMed
    74. Gallagher DA, Goetz CG, Stebbins G, Lees AJ, Schrag A. Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease. Mov Disord. 2012 Jan; 27(1):79-83. PMID: 21915909.
      View in: PubMed
    75. Goetz CG. The history of Parkinson's disease: early clinical descriptions and neurological therapies. Cold Spring Harb Perspect Med. 2011 Sep; 1(1):a008862. PMID: 22229124; PMCID: PMC3234454.
    76. Antonini A, Martinez-Martin P, Chaudhuri RK, Merello M, Hauser R, Katzenschlager R, Odin P, Stacy M, Stocchi F, Poewe W, Rascol O, Sampaio C, Schrag A, Stebbins GT, Goetz CG. Wearing-off scales in Parkinson's disease: critique and recommendations. Mov Disord. 2011 Oct; 26(12):2169-75. PMID: 21780180.
      View in: PubMed
    77. Goetz CG, Stebbins GT, Ouyang B. Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10 years. Mov Disord. 2011 Oct; 26(12):2196-200. PMID: 21755536.
      View in: PubMed
    78. Martinez-Martin P, Jeukens-Visser M, Lyons KE, Rodriguez-Blazquez C, Selai C, Siderowf A, Welsh M, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG, Schrag A. Health-related quality-of-life scales in Parkinson's disease: critique and recommendations. Mov Disord. 2011 Nov; 26(13):2371-80. PMID: 21735480.
      View in: PubMed
    79. Goldman JG, Vaughan CL, Goetz CG. An update expert opinion on management and research strategies in Parkinson's disease psychosis. Expert Opin Pharmacother. 2011 Sep; 12(13):2009-24. PMID: 21635198; PMCID: PMC3152685.
    80. Pavy-Le Traon A, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Shaftman SR, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Stebbins GT, Rascol O. The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension. Mov Disord. 2011 Sep; 26(11):1985-92. PMID: 21547951.
      View in: PubMed
    81. Goetz CG, McGhiey A. The movement disorder society and movement disorders: a modern history. Mov Disord. 2011 May; 26(6):939-46. PMID: 21626540.
      View in: PubMed
    82. Meissner WG, Frasier M, Gasser T, Goetz CG, Lozano A, Piccini P, Obeso JA, Rascol O, Schapira A, Voon V, Weiner DM, Tison F, Bezard E. Priorities in Parkinson's disease research. Nat Rev Drug Discov. 2011 May; 10(5):377-93. PMID: 21532567.
      View in: PubMed
    83. Goldman JG, Marr D, Zhou L, Ouyang B, Leurgans SE, Berry-Kravis E, Goetz CG. Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations. Mov Disord. 2011 Aug 01; 26(9):1781-2. PMID: 21506165; PMCID: PMC3142314.
    84. Högl B, Arnulf I, Comella C, Ferreira J, Iranzo A, Tilley B, Trenkwalder C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Schrag A, Goetz CG. Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov Disord. 2010 Dec 15; 25(16):2704-16. PMID: 20931631.
      View in: PubMed
    85. Goetz CG, Ouyang B, Negron A, Stebbins GT. Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study. Neurology. 2010 Nov 16; 75(20):1773-9. PMID: 20962287; PMCID: PMC2995381.
    86. Schwid SR, Bausch J, Oakes D, Schuchter L, Tanner C, Forrest M, Lang AE, Shoulson I. Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease. Mov Disord. 2010 Sep 15; 25(12):1801-8. PMID: 20669311.
      View in: PubMed
    87. Forsaa EB, Larsen JP, Wentzel-Larsen T, Goetz CG, Stebbins GT, Aarsland D, Alves G. A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol. 2010 Aug; 67(8):996-1001. PMID: 20697051.
      View in: PubMed
    88. Kompoliti K, Stebbins GT, Goetz CG, Fan W. Association between antipsychotics and body mass index when treating patients with tics. J Child Adolesc Psychopharmacol. 2010 Aug; 20(4):277-81. PMID: 20807065.
      View in: PubMed
    89. Colosimo C, Martínez-Martín P, Fabbrini G, Hauser RA, Merello M, Miyasaki J, Poewe W, Sampaio C, Rascol O, Stebbins GT, Schrag A, Goetz CG. Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations. Mov Disord. 2010 Jul 15; 25(9):1131-42. PMID: 20310033.
      View in: PubMed
    90. Goetz CG, Stebbins GT, Chmura TA, Fahn S, Poewe W, Tanner CM. Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS). Mov Disord. 2010 Jul 15; 25(9):1190-4. PMID: 20629138.
      View in: PubMed
    91. Goetz CG. Shaking up the Salpetriere: Jean-Martin Charcot and mercury-induced tremor. Neurology. 2010 May 25; 74(21):1739-42. PMID: 20498442; PMCID: PMC3462583.
    92. Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AH, Halliday G. Missing pieces in the Parkinson's disease puzzle. Nat Med. 2010 Jun; 16(6):653-61. PMID: 20495568.
      View in: PubMed
    93. Friedman JH, Alves G, Hagell P, Marinus J, Marsh L, Martinez-Martin P, Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins G, Schrag A. Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Mov Disord. 2010 May 15; 25(7):805-22. PMID: 20461797.
      View in: PubMed
    94. Goetz CG. New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease. Mov Disord. 2010; 25 Suppl 1:S104-9. PMID: 20187250.
      View in: PubMed
    95. Goetz CG. Chapter 15: Jean-Martin Charcot and the anatomo-clinical method of neurology. Handb Clin Neurol. 2010; 95:203-12. PMID: 19892118.
      View in: PubMed
    96. Goetz CG. Scales to evaluate psychosis in Parkinson's disease. Parkinsonism Relat Disord. 2009 Dec; 15 Suppl 3:S38-41. PMID: 20083004.
      View in: PubMed
    97. Goetz CG. [Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS): a new scale for the evaluation of Parkinson's disease]. Rev Neurol (Paris). 2010 Jan; 166(1):1-4. PMID: 19910010.
      View in: PubMed
    98. Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, Shoulson I. A longitudinal program for biomarker development in Parkinson's disease: a feasibility study. Mov Disord. 2009 Oct 30; 24(14):2081-90. PMID: 19691116.
      View in: PubMed
    99. Garcia-Arocena D, Yang JE, Brouwer JR, Tassone F, Iwahashi C, Berry-Kravis EM, Goetz CG, Sumis AM, Zhou L, Nguyen DV, Campos L, Howell E, Ludwig A, Greco C, Willemsen R, Hagerman RJ, Hagerman PJ. Fibroblast phenotype in male carriers of FMR1 premutation alleles. Hum Mol Genet. 2010 Jan 15; 19(2):299-312. PMID: 19864489; PMCID: PMC2796892.
    100. Goetz CG, Harter DH. Charcot and Pasteur: intersecting orbits in fin de siècle French medicine. J Hist Neurosci. 2009 Oct; 18(4):378-86. PMID: 20183219.
      View in: PubMed
    101. Huang P, Goetz CG, Woolson RF, Tilley B, Kerr D, Palesch Y, Elm J, Ravina B, Bergmann KJ, Kieburtz K. Using global statistical tests in long-term Parkinson's disease clinical trials. Mov Disord. 2009 Sep 15; 24(12):1732-9. PMID: 19514076; PMCID: PMC2813508.
    102. Goetz CG. Jean-Martin Charcot and his vibratory chair for Parkinson disease. Neurology. 2009 Aug 11; 73(6):475-8. PMID: 19667323.
      View in: PubMed
    103. Goetz CG, Nutt JG, Stebbins GT, Chmura TA. Teaching program for the Unified Dyskinesia Rating Scale. Mov Disord. 2009 Jul 15; 24(9):1296-8. PMID: 19425060.
      View in: PubMed
    104. Hinson VK, Goetz CG, Leurgans S, Fan W, Nguyen T, Hsu A. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients. Clin Neuropharmacol. 2009 Jul-Aug; 32(4):189-92. PMID: 19620848.
      View in: PubMed
    105. Diederich NJ, Fénelon G, Stebbins G, Goetz CG. Hallucinations in Parkinson disease. Nat Rev Neurol. 2009 Jun; 5(6):331-42. PMID: 19498436.
      View in: PubMed
    106. Bernard BA, Stebbins GT, Siegel S, Schultz TM, Hays C, Morrissey MJ, Leurgans S, Goetz CG. Determinants of quality of life in children with Gilles de la Tourette syndrome. Mov Disord. 2009 May 15; 24(7):1070-3. PMID: 19306279.
      View in: PubMed
    107. Barton B, Zauber SE, Goetz CG. Movement disorders caused by medical disease. Semin Neurol. 2009 Apr; 29(2):97-110. PMID: 19370491.
      View in: PubMed
    108. Evatt ML, Chaudhuri KR, Chou KL, Cubo E, Hinson V, Kompoliti K, Yang C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG. Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease. Mov Disord. 2009 Apr 15; 24(5):635-46. PMID: 19205066; PMCID: PMC4404514.
    109. Goetz CG, Stebbins GT, Wolff D, DeLeeuw W, Bronte-Stewart H, Elble R, Hallett M, Nutt J, Ramig L, Sanger T, Wu AD, Kraus PH, Blasucci LM, Shamim EA, Sethi KD, Spielman J, Kubota K, Grove AS, Dishman E, Taylor CB. Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device. Mov Disord. 2009 Mar 15; 24(4):551-6. PMID: 19086085; PMCID: PMC4161502.
    110. Olanow CW, Gracies JM, Goetz CG, Stoessl AJ, Freeman T, Kordower JH, Godbold J, Obeso JA. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis. Mov Disord. 2009 Feb 15; 24(3):336-43. PMID: 19006186.
      View in: PubMed
    111. Cubo E, Chmura T, Goetz CG. Comparison of tic characteristics between children and adults. Mov Disord. 2008 Dec 15; 23(16):2407-11. PMID: 18855922.
      View in: PubMed
    112. Goetz CG, Nutt JG, Stebbins GT. The Unified Dyskinesia Rating Scale: presentation and clinimetric profile. Mov Disord. 2008 Dec 15; 23(16):2398-403. PMID: 19025759.
      View in: PubMed
    113. Goetz CG, Emre M, Dubois B. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol. 2008 Dec; 64 Suppl 2:S81-92. PMID: 19127578.
      View in: PubMed
    114. Goldman JG, Goetz CG, Brandabur M, Sanfilippo M, Stebbins GT. Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies. Mov Disord. 2008 Nov 15; 23(15):2248-50. PMID: 18823039.
      View in: PubMed
    115. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15; 23(15):2129-70. PMID: 19025984.
      View in: PubMed
    116. Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG. Anxiety rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2008 Oct 30; 23(14):2015-25. PMID: 18792121.
      View in: PubMed
    117. Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2008 Oct 30; 23(14):2004-14. PMID: 18709683.
      View in: PubMed
    118. Louis ED, Broussolle E, Goetz CG, Krack P, Kaufmann P, Mazzoni P. Historical underpinnings of the term essential tremor in the late 19th century. Neurology. 2008 Sep 09; 71(11):856-9. PMID: 18779514; PMCID: PMC3461999.
    119. Diederich NJ, Goetz CG. The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies. Neurology. 2008 Aug 26; 71(9):677-84. PMID: 18725593.
      View in: PubMed
    120. Goetz CG, Fan W, Leurgans S. Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long-term worsening. Mov Disord. 2008 Aug 15; 23(11):1541-5. PMID: 18567004.
      View in: PubMed
    121. Goetz CG, Leurgans S, Hinson VK, Blasucci LM, Zimmerman J, Fan W, Nguyen T, Hsu A. Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments. Mov Disord. 2008 Jul 30; 23(10):1479-82. PMID: 18512751.
      View in: PubMed
    122. Diederich NJ, Leurgans S, Fan W, Chmura TA, Goetz CG. Visual hallucinations and symptoms of REM sleep behavior disorder in Parkinsonian tauopathies. Int J Geriatr Psychiatry. 2008 Jun; 23(6):598-603. PMID: 18023069.
      View in: PubMed
    123. Goetz CG, Wuu J, McDermott MP, Adler CH, Fahn S, Freed CR, Hauser RA, Olanow WC, Shoulson I, Tandon PK. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Mov Disord. 2008 Apr 15; 23(5):690-9. PMID: 18228568.
      View in: PubMed
    124. Goetz CG, Laska E, Hicking C, Damier P, Müller T, Nutt J, Warren Olanow C, Rascol O, Russ H. Placebo influences on dyskinesia in Parkinson's disease. Mov Disord. 2008 Apr 15; 23(5):700-7. PMID: 18175337; PMCID: PMC2689363.
    125. Schwarzschild MA, Schwid SR, Marek K, Watts A, Lang AE, Oakes D, Shoulson I, Ascherio A. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol. 2008 Jun; 65(6):716-23. PMID: 18413464; PMCID: PMC2574855.
    126. Fernandez HH, Aarsland D, Fénelon G, Friedman JH, Marsh L, Tröster AI, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG. Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Mov Disord. 2008 Mar 15; 23(4):484-500. PMID: 18175343.
      View in: PubMed
    127. Goetz CG. Concerning about the accuracy of data reported. Mov Disord. 2008 Mar 15; 23(4):473; author reply 473. PMID: 18383134.
      View in: PubMed
    128. Leehey MA, Berry-Kravis E, Goetz CG, Zhang L, Hall DA, Li L, Rice CD, Lara R, Cogswell J, Reynolds A, Gane L, Jacquemont S, Tassone F, Grigsby J, Hagerman RJ, Hagerman PJ. FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology. 2008 Apr 15; 70(16 Pt 2):1397-402. PMID: 18057320; PMCID: PMC2685188.
    129. Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007 Dec; 22(16):2314-24. PMID: 18098298.
      View in: PubMed
    130. Goetz CG, Deuschl G. Disclosure on author work effort. Mov Disord. 2007 Oct 31; 22(14):1989. PMID: 17969060.
      View in: PubMed
    131. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007 Sep 15; 22(12):1689-707; quiz 1837. PMID: 17542011.
      View in: PubMed
    132. Fabbrini G, Brotchie JM, Grandas F, Nomoto M, Goetz CG. Levodopa-induced dyskinesias. Mov Disord. 2007 Jul 30; 22(10):1379-89; quiz 1523. PMID: 17427940.
      View in: PubMed
    133. Goetz CG. J.-M. Charcot and simulated neurologic disease: attitudes and diagnostic strategies. Neurology. 2007 Jul 03; 69(1):103-9. PMID: 17606887.
      View in: PubMed
    134. Schrag A, Barone P, Brown RG, Leentjens AF, McDonald WM, Starkstein S, Weintraub D, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2007 Jun 15; 22(8):1077-92. PMID: 17394234; PMCID: PMC2040268.
    135. Ravina B, Marder K, Fernandez HH, Friedman JH, McDonald W, Murphy D, Aarsland D, Babcock D, Cummings J, Endicott J, Factor S, Galpern W, Lees A, Marsh L, Stacy M, Gwinn-Hardy K, Voon V, Goetz C. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord. 2007 Jun 15; 22(8):1061-8. PMID: 17266092.
      View in: PubMed
    136. Broussolle E, Krack P, Thobois S, Xie-Brustolin J, Pollak P, Goetz CG. Contribution of Jules Froment to the study of parkinsonian rigidity. Mov Disord. 2007 May 15; 22(7):909-14. PMID: 17443696.
      View in: PubMed
    137. Litvan I, Chesselet MF, Gasser T, Di Monte DA, Parker D, Hagg T, Hardy J, Jenner P, Myers RH, Price D, Hallett M, Langston WJ, Lang AE, Halliday G, Rocca W, Duyckaerts C, Dickson DW, Ben-Shlomo Y, Goetz CG, Melamed E. The etiopathogenesis of Parkinson disease and suggestions for future research. Part II. J Neuropathol Exp Neurol. 2007 May; 66(5):329-36. PMID: 17483689.
      View in: PubMed
    138. Litvan I, Halliday G, Hallett M, Goetz CG, Rocca W, Duyckaerts C, Ben-Shlomo Y, Dickson DW, Lang AE, Chesselet MF, Langston WJ, Di Monte DA, Gasser T, Hagg T, Hardy J, Jenner P, Melamed E, Myers RH, Parker D, Price DL. The etiopathogenesis of Parkinson disease and suggestions for future research. Part I. J Neuropathol Exp Neurol. 2007 Apr; 66(4):251-7. PMID: 17413315.
      View in: PubMed
    139. Goetz CG, Deuschl G. Author responsibilities and compliance with data source agreements. Mov Disord. 2007 Mar 15; 22(4):449. PMID: 17390388.
      View in: PubMed
    140. Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM, Leverenz JB, Masliah E, McKeith IG, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 2007 Mar 13; 68(11):812-9. PMID: 17353469.
      View in: PubMed
    141. Jasinska-Myga B, Opala G, Goetz CG, Tustanowski J, Ochudlo S, Gorzkowska A, Tyrpa J. Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia. Arch Neurol. 2007 Feb; 64(2):261-5. PMID: 17296843.
      View in: PubMed
    142. Goetz CG, Damier P, Hicking C, Laska E, Müller T, Olanow CW, Rascol O, Russ H. Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial. Mov Disord. 2007 Jan 15; 22(2):179-86. PMID: 17094088.
      View in: PubMed
    143. Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord. 2007 Jan; 22(1):41-7. PMID: 17115387.
      View in: PubMed
    144. Berry-Kravis E, Goetz CG, Leehey MA, Hagerman RJ, Zhang L, Li L, Nguyen D, Hall DA, Tartaglia N, Cogswell J, Tassone F, Hagerman PJ. Neuropathic features in fragile X premutation carriers. Am J Med Genet A. 2007 Jan 01; 143A(1):19-26. PMID: 17152065.
      View in: PubMed
    145. Goldman JG, Goetz CG. History of Parkinson's disease. Handb Clin Neurol. 2007; 83:107-28. PMID: 18808912.
      View in: PubMed
    146. Friedman JH, Berman RM, Goetz CG, Factor SA, Ondo WG, Wojcieszek J, Carson WH, Marcus RN. Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease. Mov Disord. 2006 Dec; 21(12):2078-81. PMID: 17013906.
      View in: PubMed
    147. Goetz CG, Vilensky JA. Early cinematographic studies of generalized dystonia. Mov Disord. 2006 Oct; 21(10):1561-5. PMID: 16830311.
      View in: PubMed
    148. Elmer L, Schwid S, Eberly S, Goetz C, Fahn S, Kieburtz K, Oakes D, Blindauer K, Salzman P, Oren S, Prisco UL, Stern M, Shoulson I. Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms. J Neurol Sci. 2006 Oct 25; 248(1-2):78-83. PMID: 16828804.
      View in: PubMed
    149. Kroonenberg PM, Oort FJ, Stebbins GT, Leurgans SE, Cubo E, Goetz CG. Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations. BMC Med Res Methodol. 2006 Jun 13; 6:26. PMID: 16772027; PMCID: PMC1538612.
    150. Goetz CG, Li JM, Wuu J, Leurgans S. Does seasonal variation affect hallucinations in PD? A longitudinal study. Mov Disord. 2006 Jun; 21(6):863-5. PMID: 16538649.
      View in: PubMed
    151. Goetz CG, Schwid SR, Eberly SW, Oakes D, Shoulson I. Safety of rasagiline in elderly patients with Parkinson disease. Neurology. 2006 May 09; 66(9):1427-9. PMID: 16682679.
      View in: PubMed
    152. Goetz CG, Fan W, Leurgans S, Bernard B, Stebbins GT. The malignant course of "benign hallucinations" in Parkinson disease. Arch Neurol. 2006 May; 63(5):713-6. PMID: 16682540.
      View in: PubMed
    153. Goetz CG. Charcot in contemporary literature. J Hist Neurosci. 2006 Mar; 15(1):22-30. PMID: 16443570.
      View in: PubMed
    154. Kompoliti K, Goetz CG, Morrissey M, Leurgans S. Gilles de la Tourette syndrome: patient's knowledge and concern of adverse effects. Mov Disord. 2006 Feb; 21(2):248-52. PMID: 16161137.
      View in: PubMed
    155. Goetz CG, Wuu J, Curgian L, Leurgans S. Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients. Mov Disord. 2006 Feb; 21(2):267-70. PMID: 16161144.
      View in: PubMed
    156. Blindauer K, Shoulson I, Oakes D, Kieburtz K, Schwid S, Fahn S, Stern M, Goetz C, Nutt J, Goren S, Sayag N, Scolnik M, Levy R, Eyal E, Salzman P, Pagano M. A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations. Arch Neurol. 2006 Feb; 63(2):210-6. PMID: 16476809.
      View in: PubMed
    157. Fénelon G, Goetz CG, Karenberg A. Hallucinations in Parkinson disease in the prelevodopa era. Neurology. 2006 Jan 10; 66(1):93-8. PMID: 16401853.
      View in: PubMed
    158. Vilensky JA, Goetz CG, Gilman S. Movement disorders associated with encephalitis lethargica: a video compilation. Mov Disord. 2006 Jan; 21(1):1-8. PMID: 16200538.
      View in: PubMed
    159. Goetz CG. What's new? Clinical progression and staging of Parkinson's disease. J Neural Transm Suppl. 2006; (70):305-8. PMID: 17017545.
      View in: PubMed
    160. Hinson VK, Weinstein S, Bernard B, Leurgans SE, Goetz CG. Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders. Parkinsonism Relat Disord. 2006 Apr; 12(3):177-80. PMID: 16364676.
      View in: PubMed
    161. Hinson VK, Cubo E, Comella CL, Goetz CG, Leurgans S. Rating scale for psychogenic movement disorders: scale development and clinimetric testing. Mov Disord. 2005 Dec; 20(12):1592-7. PMID: 16108025.
      View in: PubMed
    162. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005 Dec 27; 65(12):1863-72. PMID: 16237129.
      View in: PubMed
    163. Cubo E, Hinson VK, Goetz CG, Garcia Ruiz P, Garcia de Yebenes J, Marti MJ, Rodriguez Oroz MC, Linazasoro G, Chacón J, Vázquez A, López del Val J, Leurgans S, Wuu J. Transcultural comparison of psychogenic movement disorders. Mov Disord. 2005 Oct; 20(10):1343-5. PMID: 16001406.
      View in: PubMed
    164. Goetz C, Foertsch D, Schoenberger J, Uhl E. Thermography - a valuable tool to test hydrocephalus shunt patency. Acta Neurochir (Wien). 2005 Nov; 147(11):1167-72; discussion 1172-3. PMID: 16133774.
      View in: PubMed
    165. Schmid I, Stachel D, Graubner UB, Elsner R, Schulze S, Pöllinger B, Goetz C, Haas RJ. [Supratentorial primitive neuroectodermal tumor: a single center experience and comparison with the literature]. Klin Padiatr. 2005 May-Jun; 217(3):153-7. PMID: 15858707.
      View in: PubMed
    166. Goetz CG, Poewe W, Rascol O, Sampaio C. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Mov Disord. 2005 May; 20(5):523-39. PMID: 15818599.
      View in: PubMed
    167. Elm JJ, Goetz CG, Ravina B, Shannon K, Wooten GF, Tanner CM, Palesch YY, Huang P, Guimaraes P, Kamp C, Tilley BC, Kieburtz K. A responsive outcome for Parkinson's disease neuroprotection futility studies. Ann Neurol. 2005 Feb; 57(2):197-203. PMID: 15668964.
      View in: PubMed
    168. Diederich NJ, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord. 2005 Feb; 20(2):130-40. PMID: 15486924.
      View in: PubMed
    169. Goetz CG, Wuu J, Curgian LM, Leurgans S. Hallucinations and sleep disorders in PD: six-year prospective longitudinal study. Neurology. 2005 Jan 11; 64(1):81-6. PMID: 15642908.
      View in: PubMed
    170. Goetz CG. Movement disorders: understanding clinical trials. Lancet Neurol. 2005 Jan; 4(1):5-6. PMID: 15620847.
      View in: PubMed
    171. Guimaraes P, Kieburtz K, Goetz CG, Elm JJ, Palesch YY, Huang P, Ravina B, Tanner CM, Tilley BC. Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials. Clin Trials. 2005; 2(6):509-18. PMID: 16422311.
      View in: PubMed
    172. Berry-Kravis E, Potanos K, Weinberg D, Zhou L, Goetz CG. Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation. Ann Neurol. 2005 Jan; 57(1):144-7. PMID: 15622531.
      View in: PubMed
    173. Cubo E, Leurgans S, Goetz CG. Short-term and practice effects of metronome pacing in Parkinson's disease patients with gait freezing while in the 'on' state: randomized single blind evaluation. Parkinsonism Relat Disord. 2004 Dec; 10(8):507-10. PMID: 15542012.
      View in: PubMed
    174. Goetz CG, Stebbins GT. Assuring interrater reliability for the UPDRS motor section: utility of the UPDRS teaching tape. Mov Disord. 2004 Dec; 19(12):1453-6. PMID: 15389981.
      View in: PubMed
    175. Stebbins GT, Goetz CG, Carrillo MC, Bangen KJ, Turner DA, Glover GH, Gabrieli JD. Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology. 2004 Oct 26; 63(8):1409-16. PMID: 15505157.
      View in: PubMed
    176. Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004 Sep; 19(9):1020-8. PMID: 15372591.
      View in: PubMed
    177. Goldman JG, Goetz CG, Berry-Kravis E, Leurgans S, Zhou L. Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system. Arch Neurol. 2004 Aug; 61(8):1280-4. PMID: 15313848.
      View in: PubMed
    178. Li YJ, Hauser MA, Scott WK, Martin ER, Booze MW, Qin XJ, Walter JW, Nance MA, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Small GW, Mastaglia F, Haines JL, Pericak-Vance MA, Vance JM. Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology. 2004 Jun 08; 62(11):2005-9. PMID: 15184605.
      View in: PubMed
    179. Barboi AC, Goetz CG, Musetoiu R. The origins of scientific cinematography and early medical applications. Neurology. 2004 Jun 08; 62(11):2082-6. PMID: 15184618.
      View in: PubMed
    180. Goetz CG. Medical-legal issues in Charcot's neurologic career. Neurology. 2004 May 25; 62(10):1827-33. PMID: 15159486.
      View in: PubMed
    181. Goetz C. Re: UPDRS: Status and recommendations. Mov Disord. 2004 May; 19(5):605. PMID: 15133834.
      View in: PubMed
    182. Olanow CW, Damier P, Goetz CG, Mueller T, Nutt J, Rascol O, Serbanescu A, Deckers F, Russ H. Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study). Clin Neuropharmacol. 2004 Mar-Apr; 27(2):58-62. PMID: 15252265.
      View in: PubMed
    183. Goetz CG, LeWitt PA, Weidenman M. Standardized training tools for the UPDRS activities of daily living scale: newly available teaching program. Mov Disord. 2003 Dec; 18(12):1455-8. PMID: 14673881.
      View in: PubMed
    184. Li YJ, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CR, Hauser MA, Scott WK, Small GW, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Mastaglia F, Middleton LT, Roses AD, Saunders AM, Schmechel DE, Gullans SR, Haines JL, Gilbert JR, Vance JM, Pericak-Vance MA, Hulette C, Welsh-Bohmer KA. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet. 2003 Dec 15; 12(24):3259-67. PMID: 14570706.
      View in: PubMed
    185. Pappert EJ, Goetz CG, Louis ED, Blasucci L, Leurgans S. Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome. Neurology. 2003 Oct 14; 61(7):936-40. PMID: 14557563.
      View in: PubMed
    186. Goetz CG, Janko K, Blasucci L, Jaglin JA. Impact of placebo assignment in clinical trials of Parkinson's disease. Mov Disord. 2003 Oct; 18(10):1146-9. PMID: 14534918.
      View in: PubMed
    187. Cubo E, Moore CG, Leurgans S, Goetz CG. Wheeled and standard walkers in Parkinson's disease patients with gait freezing. Parkinsonism Relat Disord. 2003 Oct; 10(1):9-14. PMID: 14499200.
      View in: PubMed
    188. Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, Shannon KM, Nauert GM, Perl DP, Godbold J, Freeman TB. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol. 2003 Sep; 54(3):403-14. PMID: 12953276.
      View in: PubMed
    189. Diederich NJ, Pieri V, Goetz CG. Coping strategies for visual hallucinations in Parkinson's disease. Mov Disord. 2003 Jul; 18(7):831-2. PMID: 12815665.
      View in: PubMed
    190. Hinson VK, Goetz CG. Torsion Dystonia in Children. Curr Treat Options Neurol. 2003 Jul; 5(4):291-297. PMID: 12791196.
      View in: PubMed
    191. Oliveira SA, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons KE, Pahwa R, Stern MB, Hiner BC, Jankovic J, Ondo WG, Allen FH, Scott BL, Goetz CG, Small GW, Mastaglia FL, Stajich JM, Zhang F, Booze MW, Reaves JA, Middleton LT, Haines JL, Pericak-Vance MA, Vance JM, Martin ER. Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. Arch Neurol. 2003 Jul; 60(7):975-80. PMID: 12873854.
      View in: PubMed
    192. Factor SA, Feustel PJ, Friedman JH, Comella CL, Goetz CG, Kurlan R, Parsa M, Pfeiffer R. Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology. 2003 Jun 10; 60(11):1756-61. PMID: 12796526.
      View in: PubMed
    193. Goetz CG. Pierre Marie: gifted intellect, poor timing and unchecked emotionality. J Hist Neurosci. 2003 Jun; 12(2):154-66. PMID: 12953618.
      View in: PubMed
    194. Berry-Kravis E, Lewin F, Wuu J, Leehey M, Hagerman R, Hagerman P, Goetz CG. Tremor and ataxia in fragile X premutation carriers: blinded videotape study. Ann Neurol. 2003 May; 53(5):616-23. PMID: 12730995.
      View in: PubMed
    195. Oliveira SA, Scott WK, Martin ER, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Ondo WG, Allen FH, Scott BL, Goetz CG, Small GW, Mastaglia F, Stajich JM, Zhang F, Booze MW, Winn MP, Middleton LT, Haines JL, Pericak-Vance MA, Vance JM. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann Neurol. 2003 May; 53(5):624-9. PMID: 12730996.
      View in: PubMed
    196. Goetz CG. [Progressive supranuclear palsy]. Rev Neurol (Paris). 2003 May; 159(5 Pt 2):3S25-9. PMID: 12773885.
      View in: PubMed
    197. Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KD, Shults C, Wenning GK. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord. 2003 May; 18(5):467-86. PMID: 12722160.
      View in: PubMed
    198. Goetz CG. The prefaces by Charcot: leitmotifs of an international career. Neurology. 2003 Apr 22; 60(8):1333-40. PMID: 12707438.
      View in: PubMed
    199. van der Walt JM, Martin ER, Scott WK, Zhang F, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Mastaglia F, Roses AD, Stajich JM, Booze MW, Fujiwara K, Gibson RA, Middleton LT, Scott BL, Pericak-Vance MA, Vance JM. Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease. Neurology. 2003 Apr 08; 60(7):1189-91. PMID: 12682333.
      View in: PubMed
    200. Diederich NJ, Moore CG, Leurgans SE, Chmura TA, Goetz CG. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset. Arch Neurol. 2003 Apr; 60(4):529-33. PMID: 12707066.
      View in: PubMed
    201. Goetz CG, Leurgans S, Lang AE, Litvan I. Progression of gait, speech and swallowing deficits in progressive supranuclear palsy. Neurology. 2003 Mar 25; 60(6):917-22. PMID: 12654953.
      View in: PubMed
    202. van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Mastaglia F, Stajich JM, McLaurin AC, Middleton LT, Scott BL, Schmechel DE, Pericak-Vance MA, Vance JM. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet. 2003 Apr; 72(4):804-11. PMID: 12618962; PMCID: PMC1180345.
    203. Goetz CG. Treatment of advanced Parkinson's disease: an evidence-based analysis. Adv Neurol. 2003; 91:213-28. PMID: 12442680.
      View in: PubMed
    204. Goetz CG, Chmura TA, Lanska D. Part 1: the history of 19th century neurology and the American Neurological Association. Ann Neurol. 2003; 53 Suppl 4:S2-S26. PMID: 12722087.
      View in: PubMed
    205. Goetz CG. History of the extensor plantar response: Babinski and Chaddock signs. Semin Neurol. 2002 Dec; 22(4):391-8. PMID: 12539060.
      View in: PubMed
    206. Goetz CG. Jean-Martin Charcot and the aging brain. Arch Neurol. 2002 Nov; 59(11):1821-4. PMID: 12433272.
      View in: PubMed
    207. Diederich NJ, Raman R, Leurgans S, Goetz CG. Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. Arch Neurol. 2002 Aug; 59(8):1249-52. PMID: 12164720.
      View in: PubMed
    208. Horn SS, Goetz CG. The election of Sarah McNutt as the first woman member of the American Neurological Association. Neurology. 2002 Jul 09; 59(1):113-7. PMID: 12105317.
      View in: PubMed
    209. Kompoliti K, Adler CH, Raman R, Pincus JH, Leibowitz MT, Ferry JJ, Blasucci L, Caviness JN, Leurgans S, Chase WM, Yones LC, Tan E, Carvey P, Goetz CG. Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics. Neurology. 2002 May 14; 58(9):1418-22. PMID: 12011296.
      View in: PubMed
    210. Rascol O, Goetz C, Koller W, Poewe W, Sampaio C. Treatment interventions for Parkinson's disease: an evidence based assessment. Lancet. 2002 May 04; 359(9317):1589-98. PMID: 12047983.
      View in: PubMed
    211. Goetz CG, Hinson VK. Therapies for movement disorders. Arch Neurol. 2002 May; 59(5):699-702. PMID: 12020248.
      View in: PubMed
    212. Pramstaller PP, Künig G, Leenders K, Kann M, Hedrich K, Vieregge P, Goetz CG, Klein C. Parkin mutations in a patient with hemiparkinsonism-hemiatrophy: a clinical-genetic and PET study. Neurology. 2002 Mar 12; 58(5):808-10. PMID: 11889248.
      View in: PubMed
    213. Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Allen FA, Goetz CG, Mastaglia F, Stajich JM, Gibson RA, Middleton LT, Saunders AM, Scott BL, Small GW, Nicodemus KK, Reed AD, Schmechel DE, Welsh-Bohmer KA, Conneally PM, Roses AD, Gilbert JR, Vance JM, Haines JL, Pericak-Vance MA. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet. 2002 Apr; 70(4):985-93. PMID: 11875758; PMCID: PMC379130.
    214. Goetz CG, Leurgans S, Raman R. Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease. Mov Disord. 2002 Mar; 17(2):283-8. PMID: 11921113.
      View in: PubMed
    215. Goetz CG, Carvey PM, Pappert EJ, Vu TQ, Leurgans SE. The role of the serotonin system in animal models of myoclonus. Adv Neurol. 2002; 89:244-8. PMID: 11968451.
      View in: PubMed
    216. Goetz CG, Leurgans S, Pappert EJ, Raman R, Stemer AB. Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology. 2001 Dec 11; 57(11):2078-82. PMID: 11739829.
      View in: PubMed
    217. Goetz CG, Aminoff MJ. The Brown-Séquard and S. Weir Mitchell letters. Neurology. 2001 Dec 11; 57(11):2100-4. PMID: 11739833.
      View in: PubMed
    218. Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Laing NG, Stajich JM, Ribble RC, Booze MW, Rogala A, Hauser MA, Zhang F, Gibson RA, Middleton LT, Roses AD, Haines JL, Scott BL, Pericak-Vance MA, Vance JM. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA. 2001 Nov 14; 286(18):2245-50. PMID: 11710889; PMCID: PMC3973175.
    219. Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Laing NG, Stajich JM, Slotterbeck B, Booze MW, Ribble RC, Rampersaud E, West SG, Gibson RA, Middleton LT, Roses AD, Haines JL, Scott BL, Vance JM, Pericak-Vance MA. Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA. 2001 Nov 14; 286(18):2239-44. PMID: 11710888.
      View in: PubMed
    220. Kompoliti K, Goetz CG, Leurgans S, Raman R, Comella CL. Estrogen, progesterone, and tic severity in women with Gilles de la Tourette syndrome. Neurology. 2001 Oct 23; 57(8):1519. PMID: 11673608.
      View in: PubMed
    221. Goetz CG, Chmura TA, Lanska DJ. History of movement disorders as a neurological specialty: Part 14 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000. Mov Disord. 2001 Sep; 16(5):954-9. PMID: 11746630.
      View in: PubMed
    222. Goetz CG, Chmura TA, Lanska DJ. Medical art and photography in the history of movement disorders: Part 13 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000. Mov Disord. 2001 Sep; 16(5):947-53. PMID: 11746629.
      View in: PubMed
    223. Cubo E, Gracies JM, Benabou R, Olanow CW, Raman R, Leurgans S, Goetz CG. Early morning off-medication dyskinesias, dystonia, and choreic subtypes. Arch Neurol. 2001 Sep; 58(9):1379-82. PMID: 11559308.
      View in: PubMed
    224. Goetz CG, Chmura TA, Lanska DJ. Seminal figures in the history of movement disorders: Gilles de la Tourette, Oppenheim, the Vogts, von Economo, Wilson, and Marsden. Part 12 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000. Mov Disord. 2001 Sep; 16(5):940-6. PMID: 11746628.
      View in: PubMed
    225. Goetz CG. Poor Beard!! Charcot's internationalization of neurasthenia, the "American disease". Neurology. 2001 Aug 14; 57(3):510-4. PMID: 11502922.
      View in: PubMed
    226. Kujawa KA, Niemi VR, Tomasi MA, Mayer NW, Cochran E, Goetz CG. Ballistic-choreic movements as the presenting feature of renal cancer. Arch Neurol. 2001 Jul; 58(7):1133-5. PMID: 11448303.
      View in: PubMed
    227. Lanska DJ, Goetz CG, Chmura TA. Development of instruments for abnormal movements: dynamometers, the dynamograph, and tremor recorders. Part 9 of the MDS-Sponsored History of Movement Disorders Exhibit, Barcelona, June 2000. Mov Disord. 2001 Jul; 16(4):736-41. PMID: 11481701.
      View in: PubMed
    228. Lanska DJ, Goetz CG, Chmura TA. Seminal figures in the History of Movement Disorders: Hammond, Osler, and Huntington. Part 11 of the MDS-Sponsored History of Movement Disorders Exhibit, Barcelona, June 2000. Mov Disord. 2001 Jul; 16(4):749-53. PMID: 11481703.
      View in: PubMed
    229. Lanska DJ, Goetz CG, Chmura TA. Development of instruments for abnormal movements: postural sway and gait analyses. Part 10 of the MDS-Sponsored History of Movement Disorders Exhibit, Barcelona, June 2000. Mov Disord. 2001 Jul; 16(4):742-8. PMID: 11481702.
      View in: PubMed
    230. Goetz CG, Leurgans S, Chmura TA. Home alone: methods to maximize tic expression for objective videotape assessments in Gilles de la Tourette syndrome. Mov Disord. 2001 Jul; 16(4):693-7. PMID: 11481693.
      View in: PubMed
    231. Goetz CG, Chmura TA, Lanska DJ. Parkinsonism-plus syndromes: Part 7 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000. Mov Disord. 2001 May; 16(3):541. PMID: 11391756.
      View in: PubMed
    232. Goetz CG, Chmura TA, Lanska DJ. History of Myoclonus: Part 8 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000. Mov Disord. 2001 May; 16(3):545-7. PMID: 11391757.
      View in: PubMed
    233. Goetz CG, Chmura TA, Lanska DJ. Seminal figures in the history of movement disorders: Sydenham, Parkinson, and Charcot: Part 6 of the MDS-sponsored history of Movement Disorders exhibit, Barcelona, June 2000. Mov Disord. 2001 May; 16(3):537-40. PMID: 11391755.
      View in: PubMed
    234. Goetz CG. [History of dystonia]. Rev Neurol (Paris). 2001 Apr; 157(4):446-9. PMID: 11398019.
      View in: PubMed
    235. Goetz CG, Chmura TA, Lanska DJ. History of chorea: part 3 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000. Mov Disord. 2001 Mar; 16(2):331-8. PMID: 11295790.
      View in: PubMed
    236. Goetz CG, Chmura TA, Lanska DJ. History of tic disorders and Gilles de la Tourette syndrome: part 5 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000. Mov Disord. 2001 Mar; 16(2):346-9. PMID: 11295792.
      View in: PubMed
    237. Goetz CG, Chmura TA, Lanska DJ. History of dystonia: part 4 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June, 2000. Mov Disord. 2001 Mar; 16(2):339-45. PMID: 11295791.
      View in: PubMed
    238. Goetz CG, Horn SS. Treatment of tremor and dystonia. Neurol Clin. 2001 Feb; 19(1):129-44, vi-vii. PMID: 11471761.
      View in: PubMed
    239. Rascol O, Nutt JG, Blin O, Goetz CG, Trugman JM, Soubrouillard C, Carter JH, Currie LJ, Fabre N, Thalamas C, Giardina WW, Wright S. Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease. Arch Neurol. 2001 Feb; 58(2):249-54. PMID: 11176963.
      View in: PubMed
    240. Goetz CG, Burke PF, Leurgans S, Berry-Kravis E, Blasucci LM, Raman R, Zhou L. Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study. Arch Neurol. 2001 Feb; 58(2):209-13. PMID: 11176958.
      View in: PubMed
    241. Goetz CG, Chmura TA, Lanska DJ. The history of Parkinson's disease: part 2 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, June, 2000. Mov Disord. 2001 Jan; 16(1):156-61. PMID: 11215579.
      View in: PubMed
    242. Goetz CG, Kompoliti K. Rating scales and quantitative assessment of tics. Adv Neurol. 2001; 85:31-42. PMID: 11530438.
      View in: PubMed
    243. Kompoliti K, Goetz CG, Vu TQ, Carvey PM, Leurgans S, Raman R. Estrogen supplementation in the posthypoxic myoclonus rat model. Clin Neuropharmacol. 2001 Jan-Feb; 24(1):58-61. PMID: 11290883.
      View in: PubMed
    244. Goetz CG, Chmura TA, Lanska DJ. The basal ganglia: part 1 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, June 2000. Mov Disord. 2001 Jan; 16(1):152-5. PMID: 11215578.
      View in: PubMed
    245. Leckman JF, Cohen DJ, Goetz CG, Jankovic J. Tourette syndrome: pieces of the puzzle. Adv Neurol. 2001; 85:369-90. PMID: 11530445.
      View in: PubMed
    246. Kompoliti K, Comella CL, Jaglin JA, Leurgans S, Raman R, Goetz CG. Menstrual-related changes in motoric function in women with Parkinson's disease. Neurology. 2000 Nov 28; 55(10):1572-5. PMID: 11094119.
      View in: PubMed
    247. Lanska DJ, Goetz CG. Romberg's sign: development, adoption, and adaptation in the 19th century. Neurology. 2000 Oct 24; 55(8):1201-6. PMID: 11071500.
      View in: PubMed
    248. Cubo E, Goetz CG. Dystonia secondary to Sjögren-Larsson syndrome. Neurology. 2000 Oct 24; 55(8):1236-7. PMID: 11071513.
      View in: PubMed
    249. Kujawa K, Leurgans S, Raman R, Blasucci L, Goetz CG. Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease. Arch Neurol. 2000 Oct; 57(10):1461-3. PMID: 11030798.
      View in: PubMed
    250. Goetz CG, Blasucci LM, Leurgans S, Pappert EJ. Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients. Neurology. 2000 Sep 26; 55(6):789-94. PMID: 10993997.
      View in: PubMed
    251. Diederich NJ, Alesch F, Goetz CG. Visual hallucinations induced by deep brain stimulation in Parkinson's disease. Clin Neuropharmacol. 2000 Sep-Oct; 23(5):287-9. PMID: 11154099.
      View in: PubMed
    252. Goetz CG, Meisel E. Biological neurotoxins. Neurol Clin. 2000 Aug; 18(3):719-40. PMID: 10873240.
      View in: PubMed
    253. Goetz CG. Battle of the titans: Charcot and Brown-Séquard on cerebral localization. Neurology. 2000 May 09; 54(9):1840-7. PMID: 10802795.
      View in: PubMed
    254. Palfi S, Leventhal L, Goetz CG, Hantraye T, Roitberg BZ, Sramek J, Emborg M, Kordower JH. Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys. Mov Disord. 2000 May; 15(3):524-30. PMID: 10830419.
      View in: PubMed
    255. Goetz CG, Stebbins GT, Blasucci LM. Differential progression of motor impairment in levodopa-treated Parkinson's disease. Mov Disord. 2000 May; 15(3):479-84. PMID: 10830412.
      View in: PubMed
    256. Stebbins GT, Gabrieli JD, Shannon KM, Penn RD, Goetz CG. Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's disease. Brain Cogn. 2000 Apr; 42(3):348-63. PMID: 10753484.
      View in: PubMed
    257. Goetz CG. William Osler: on Chorea: on Charcot. Ann Neurol. 2000 Mar; 47(3):404-7. PMID: 10716267.
      View in: PubMed
    258. Sallee FR, Kurlan R, Goetz CG, Singer H, Scahill L, Law G, Dittman VM, Chappell PB. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry. 2000 Mar; 39(3):292-9. PMID: 10714048.
      View in: PubMed
    259. Diederich NJ, Goetz CG. Neuropsychological and behavioral aspects of transplants in Parkinson's disease and Huntington's disease. Brain Cogn. 2000 Mar; 42(2):294-306. PMID: 10744925.
      View in: PubMed
    260. Diederich NJ, Pieri V, Goetz CG. [Visual hallucinations in Parkinson and Charles Bonnet Syndrome patients. A phenomenological and pathogenetic comparison]. Fortschr Neurol Psychiatr. 2000 Mar; 68(3):129-36. PMID: 10758844.
      View in: PubMed
    261. Kompoliti K, Goetz CG, Leurgans S, Morrissey M, Siegel IM. "On" freezing in Parkinson's disease: resistance to visual cue walking devices. Mov Disord. 2000 Mar; 15(2):309-12. PMID: 10752582.
      View in: PubMed
    262. Cubo E, Stebbins GT, Golbe LI, Nieves A, Leurgans S, Goetz CG, Kompoliti K. Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale. Mov Disord. 2000 Mar; 15(2):276-9. PMID: 10752576.
      View in: PubMed
    263. Goetz CG. Amyotrophic lateral sclerosis: early contributions of Jean-Martin Charcot. Muscle Nerve. 2000 Mar; 23(3):336-43. PMID: 10679709.
      View in: PubMed
    264. Goetz CG, Leurgans S, Raman R, Stebbins GT. Objective changes in motor function during placebo treatment in PD. Neurology. 2000 Feb 08; 54(3):710-4. PMID: 10680808.
      View in: PubMed
    265. Kompoliti K, Wang QE, Goetz CG, Leurgans S, Raman R. Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology. 2000 Jan 25; 54(2):458-62. PMID: 10668714.
      View in: PubMed
    266. Kompoliti K, Goetz CG. Therapeutic approaches. Adv Neurol. 2000; 82:217-21. PMID: 10624485.
      View in: PubMed
    267. Pieri V, Diederich NJ, Raman R, Goetz CG. Decreased color discrimination and contrast sensitivity in Parkinson's disease. J Neurol Sci. 2000 Jan 01; 172(1):7-11. PMID: 10620653.
      View in: PubMed
    268. Goetz CG. Nineteenth century studies of atypical parkinsonism: Charcot and his Salpêtrière School. Adv Neurol. 2000; 82:1-8. PMID: 10624466.
      View in: PubMed
    269. Goetz CG, Vu TQ, Carvey PM, Leurgans S. Posthypoxic myoclonus in the rat: natural history, stability, and serotonergic influences. Mov Disord. 2000; 15 Suppl 1:39-46. PMID: 10755271.
      View in: PubMed
    270. Agid Y, Ahlskog E, Albanese A, Calne D, Chase T, De Yebenes J, Factor S, Fahn S, Gershanik O, Goetz C, Koller W, Kurth M, Lang A, Lees A, Lewitt P, Marsden D, Melamed E, Michel PP, Mizuno Y, Obeso J, Oertel W, Olanow W, Poewe W, Pollak P, Tolosa E, et al. Levodopa in the treatment of Parkinson's disease: a consensus meeting. Mov Disord. 1999 Nov; 14(6):911-3. PMID: 10584663.
      View in: PubMed
    271. Kordower JH, Goetz CG. The first miracle in neurodegenerative disease: the discovery of oral levodopa. Brain Res Bull. 1999 Nov-Dec; 50(5-6):377-8. PMID: 10643443.
      View in: PubMed
    272. Freeman TB, Vawter DE, Leaverton PE, Godbold JH, Hauser RA, Goetz CG, Olanow CW. Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. N Engl J Med. 1999 Sep 23; 341(13):988-92. PMID: 10498497.
      View in: PubMed
    273. Scott WK, Yamaoka LH, Stajich JM, Scott BL, Vance JM, Roses AD, Pericak-Vance MA, Watts RL, Nance M, Hubble J, Koller W, Stern MB, Colcher A, Allen FH, Hiner BC, Jankovic J, Ondo W, Laing NG, Mastaglia F, Goetz C, Pappert E, Small GW, Masterman D, Haines JL, Davies TL. The alpha-synuclein gene is not a major risk factor in familial Parkinson disease. Neurogenetics. 1999 Sep; 2(3):191-2. PMID: 10541595.
      View in: PubMed
    274. Kompoliti K, Goetz CG, Gajdusek DC, Cubo E. Movement disorders in Kuru. Mov Disord. 1999 Sep; 14(5):800-4. PMID: 10495041.
      View in: PubMed
    275. Kordower JH, Palfi S, Chen EY, Ma SY, Sendera T, Cochran EJ, Cochran EJ, Mufson EJ, Penn R, Goetz CG, Comella CD. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann Neurol. 1999 Sep; 46(3):419-24. PMID: 10482276.
      View in: PubMed
    276. Stebbins GT, Goetz CG, Lang AE, Cubo E. Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off-state. Mov Disord. 1999 Jul; 14(4):585-9. PMID: 10435494.
      View in: PubMed
    277. Barboi AC, Goetz CG. Parkinson's disease. Clin Neuropharmacol. 1999 Jul-Aug; 22(4):184-91. PMID: 10442246.
      View in: PubMed
    278. Goetz CG. Charcot and the myth of misogyny. Neurology. 1999 May 12; 52(8):1678-86. PMID: 10331699.
      View in: PubMed
    279. Goetz CG, Pappert EJ, Louis ED, Raman R, Leurgans S. Advantages of a modified scoring method for the Rush Video-Based Tic Rating Scale. Mov Disord. 1999 May; 14(3):502-6. PMID: 10348478.
      View in: PubMed
    280. Goetz CG, Blasucci L, Stebbins GT. Switching dopamine agonists in advanced Parkinson's disease: is rapid titration preferable to slow? Neurology. 1999 Apr 12; 52(6):1227-9. PMID: 10214748.
      View in: PubMed
    281. Stebbins GT, Gabrieli JD, Masciari F, Monti L, Goetz CG. Delayed recognition memory in Parkinson's disease: a role for working memory? Neuropsychologia. 1999 Apr; 37(4):503-10. PMID: 10215097.
      View in: PubMed
    282. Pappert EJ, Goetz CG, Niederman FG, Raman R, Leurgans S. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease. Mov Disord. 1999 Jan; 14(1):117-21. PMID: 9918353.
      View in: PubMed
    283. Goetz CG. Hallucinations in Parkinson's disease: the clinical syndrome. Adv Neurol. 1999; 80:419-23. PMID: 10410750.
      View in: PubMed
    284. Bakdash T, Goetz CG, Singer HS, Cardoso F. A child with recurrent episodes of involuntary movements. Mov Disord. 1999 Jan; 14(1):146-54. PMID: 9918359.
      View in: PubMed
    285. Goetz CG. Rating scales for dyskinesias in Parkinson's disease. Mov Disord. 1999; 14 Suppl 1:48-53. PMID: 10493403.
      View in: PubMed
    286. Pappert EJ, Goetz CG, Vu TQ, Ling ZD, Leurgans S, Raman R, Carvey PM. Animal model of posthypoxic myoclonus: effects of serotonergic antagonists. Neurology. 1999 Jan 01; 52(1):16-21. PMID: 9921842.
      View in: PubMed
    287. Diederich NJ, Goetz CG, Raman R, Pappert EJ, Leurgans S, Piery V. Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin Neuropharmacol. 1998 Sep-Oct; 21(5):289-95. PMID: 9789709.
      View in: PubMed
    288. Goetz CG, Vogel C, Tanner CM, Stebbins GT. Early dopaminergic drug-induced hallucinations in parkinsonian patients. Neurology. 1998 Sep; 51(3):811-4. PMID: 9748031.
      View in: PubMed
    289. Kompoliti K, Goetz CG, Litvan I, Jellinger K, Verny M. Pharmacological therapy in progressive supranuclear palsy. Arch Neurol. 1998 Aug; 55(8):1099-102. PMID: 9708960.
      View in: PubMed
    290. Kompoliti K, Goetz CG. Neuropharmacology in the elderly. Neurol Clin. 1998 Aug; 16(3):599-610. PMID: 9666039.
      View in: PubMed
    291. Kompoliti K, Goetz CG, Boeve BF, Maraganore DM, Ahlskog JE, Marsden CD, Bhatia KP, Greene PE, Przedborski S, Seal EC, Burns RS, Hauser RA, Gauger LL, Factor SA, Molho ES, Riley DE. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol. 1998 Jul; 55(7):957-61. PMID: 9678313.
      View in: PubMed
    292. Stebbins GT, Goetz CG. Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section. Mov Disord. 1998 Jul; 13(4):633-6. PMID: 9686766.
      View in: PubMed
    293. Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chaudhuri KR, Lai EC, D'Olhaberriague L, Pearce RK, Agid Y. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol. 1998 Jul; 55(7):969-78. PMID: 9678315.
      View in: PubMed
    294. Goetz CG. Influence of COMT inhibition on levodopa pharmacology and therapy. Neurology. 1998 May; 50(5 Suppl 5):S26-30. PMID: 9591519.
      View in: PubMed
    295. Goetz CG. Highlights of the North American and European experiences. Neurology. 1998 May; 50(5 Suppl 5):S15-6. PMID: 9591517.
      View in: PubMed
    296. Goetz CG. Georges Guillain's neurologic exploration of America. Neurology. 1998 May; 50(5):1451-5. PMID: 9596004.
      View in: PubMed
    297. Goetz CG. New lessons from old drugs: amantadine and Parkinson's disease. Neurology. 1998 May; 50(5):1211-2. PMID: 9595964.
      View in: PubMed
    298. Kompoliti K, Goetz CG. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome. Mov Disord. 1998 May; 13(3):477-80. PMID: 9613740.
      View in: PubMed
    299. Buchman AS, Comella CL, Leurgans S, Stebbins GT, Goetz CG. The effect of changes in head posture on the patterns of muscle activity in cervical dystonia (CD). Mov Disord. 1998 May; 13(3):490-6. PMID: 9613743.
      View in: PubMed
    300. Pappert EJ, Goetz CG, Stebbins GT, Belden M, Carvey PM. 5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes. Eur J Pharmacol. 1998 Apr 17; 347(1):51-6. PMID: 9650847.
      View in: PubMed
    301. Diederich NJ, Goetz CG. Drug-induced movement disorders. Neurol Clin. 1998 Feb; 16(1):125-39. PMID: 9421544.
      View in: PubMed
    302. Goetz CG, Pappert EJ, Blasucci LM, Stebbins GT, Ling ZD, Nora MV, Carvey PM. Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations. Neurology. 1998 Feb; 50(2):515-7. PMID: 9484386.
      View in: PubMed
    303. Litvan I, Booth V, Wenning GK, Bartko JJ, Goetz CG, McKee A, Jankovic J, Jellinger K, Lai EC, Brandel JP, Verny M, Chaudhuri KR, Pearce RK, Agid Y. Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. J Neural Transm (Vienna). 1998; 105(2-3):217-27. PMID: 9660099.
      View in: PubMed
    304. Bennett DA, Shannon KM, Beckett LA, Goetz CG, Wilson RS. Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology. 1997 Dec; 49(6):1580-7. PMID: 9409350.
      View in: PubMed
    305. Goetz CG. Eye signs and tic disorders: Gilles de la Tourette's syndrome. J Am Optom Assoc. 1997 Nov; 68(11):688-92. PMID: 9409103.
      View in: PubMed
    306. Kompoliti K, Pappert EJ, Goetz CG, Ford B, Wood NW. Progressive cognitive decline with truncal/limb ataxia and ballistic movements. Mov Disord. 1997 Nov; 12(6):1075-84. PMID: 9399242.
      View in: PubMed
    307. Goetz CG, Stebbins GT, Blasucci LM, Grobman MS. Efficacy of a patient-training videotape on motor fluctuations for on-off diaries in Parkinson's disease. Mov Disord. 1997 Nov; 12(6):1039-41. PMID: 9399233.
      View in: PubMed
    308. Watts RL, Subramanian T, Freeman A, Goetz CG, Penn RD, Stebbins GT, Kordower JH, Bakay RA. Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: two-year follow-up study. Exp Neurol. 1997 Oct; 147(2):510-7. PMID: 9344575.
      View in: PubMed
    309. Litvan I, Goetz CG, Jankovic J, Wenning GK, Booth V, Bartko JJ, McKee A, Jellinger K, Lai EC, Brandel JP, Verny M, Chaudhuri KR, Pearce RK, Agid Y. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol. 1997 Aug; 54(8):937-44. PMID: 9267967.
      View in: PubMed
    310. Pappert EJ, Lipton JW, Goetz CG, Ling ZD, Stebbins GT, Carvey PM. The stability of carbidopa in solution. Mov Disord. 1997 Jul; 12(4):608-10. PMID: 9251084.
      View in: PubMed
    311. Comella CL, Stebbins GT, Goetz CG, Chmura TA, Bressman SB, Lang AE. Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. Mov Disord. 1997 Jul; 12(4):570-5. PMID: 9251076.
      View in: PubMed
    312. Litvan I, Agid Y, Sastry N, Jankovic J, Wenning GK, Goetz CG, Verny M, Brandel JP, Jellinger K, Chaudhuri KR, McKee A, Lai EC, Pearce RK, Bartko JJ, Sastrj N. What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study. Neurology. 1997 Jul; 49(1):62-9. PMID: 9222171.
      View in: PubMed
    313. Kordower JH, Freeman TB, Bakay RA, Goetz CG, Olanow CW. Treatment with fetal allografts. Neurology. 1997 Jun; 48(6):1737-8. PMID: 9191805.
      View in: PubMed
    314. Freeman TB, Vawter D, Goetz CG, Leaverton PE, Hauser RA, Sanberg PR, Godbold JH, Olanow CW. Toward the use of surgical placebo-controlled trials. Transplant Proc. 1997 Jun; 29(4):1925. PMID: 9193457.
      View in: PubMed
    315. Kompoliti K, Goetz CG. Tourette syndrome. Clinical rating and quantitative assessment of tics. Neurol Clin. 1997 May; 15(2):239-54. PMID: 9106419.
      View in: PubMed
    316. Goetz CG. Jean-Martin Charcot and Silas Weir Mitchell. Neurology. 1997 Apr; 48(4):1128-32. PMID: 9109917.
      View in: PubMed
    317. Gabrieli JD, Stebbins GT, Singh J, Willingham DB, Goetz CG. Intact mirror-tracing and impaired rotary-pursuit skill learning in patients with Huntington's disease: evidence for dissociable memory systems in skill learning. Neuropsychology. 1997 Apr; 11(2):272-81. PMID: 9110333.
      View in: PubMed
    318. Kordower JH, Goetz CG, Freeman TB, Olanow CW. Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery. Exp Neurol. 1997 Mar; 144(1):41-6. PMID: 9126150.
      View in: PubMed
    319. Goetz CG. New strategies with dopaminergic drugs: modified formulations of levodopa and novel agonists. Exp Neurol. 1997 Mar; 144(1):17-20. PMID: 9126145.
      View in: PubMed
    320. Diederich NJ, Comella CL, Goetz CG. [Botulin toxin: principles of action and neurological indications]. Presse Med. 1997 Feb 01; 26(2):96-100. PMID: 9082423.
      View in: PubMed
    321. Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, Lai EC, Verny M, Ray-Chaudhuri K, McKee A, Jellinger K, Pearce RK, Bartko JJ. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology. 1997 Jan; 48(1):119-25. PMID: 9008506.
      View in: PubMed
    322. Pappert EJ, Goetz CG, Niederman F, Ling ZD, Stebbins GT, Carvey PM. Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation. Neurology. 1996 Dec; 47(6):1493-5. PMID: 8960733.
      View in: PubMed
    323. Goetz CG. An early photographic case of probable progressive supranuclear palsy. Mov Disord. 1996 Nov; 11(6):617-8. PMID: 8914085.
      View in: PubMed
    324. Pappert EJ, Tangney CC, Goetz CG, Ling ZD, Lipton JW, Stebbins GT, Carvey PM. Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels. Neurology. 1996 Oct; 47(4):1037-42. PMID: 8857741.
      View in: PubMed
    325. Diederich N, Hilger C, Goetz CG, Keipes M, Hentges F, Vieregge P, Metz H. Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease. Ann Neurol. 1996 Sep; 40(3):463-5. PMID: 8797539.
      View in: PubMed
    326. Mady S, Wax P, Wang D, Goetz C, Hadley C, Love R. Pediatric clozapine intoxication. Am J Emerg Med. 1996 Sep; 14(5):462-3. PMID: 8765110.
      View in: PubMed
    327. Bonduelle M, Goetz CG. Charcot and aphasia. J Hist Neurosci. 1996 Aug; 5(2):108-16. PMID: 11619038.
      View in: PubMed
    328. Goetz CG, Pappert EJ. Early American professorships in neurology. Ann Neurol. 1996 Aug; 40(2):258-63. PMID: 8773612.
      View in: PubMed
    329. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996 Jul; 47(1):1-9. PMID: 8710059.
      View in: PubMed
    330. Fahn S, Brin MF, Dwork AJ, Weiner WJ, Goetz CG, Rajput AH. Case 1, 1996: rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma. Mov Disord. 1996 May; 11(3):298-310. PMID: 8723148.
      View in: PubMed
    331. Goetz CG, Diederich NJ. There is a renaissance of interest in pallidotomy for Parkinson's disease. Nat Med. 1996 May; 2(5):510-4. PMID: 8616702.
      View in: PubMed
    332. Weissenborn K, Rückert N, Ehrenheim C, Schellong S, Goetz C, Lubach D. Neuropsychological deficits in patients with Sneddon's syndrome. J Neurol. 1996 Apr; 243(4):357-63. PMID: 8965111.
      View in: PubMed
    333. Litvan I, Agid Y, Jankovic J, Goetz C, Brandel JP, Lai EC, Wenning G, D'Olhaberriague L, Verny M, Chaudhuri KR, McKee A, Jellinger K, Bartko JJ, Mangone CA, Pearce RK. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology. 1996 Apr; 46(4):922-30. PMID: 8780065.
      View in: PubMed
    334. Bennett DA, Beckett LA, Murray AM, Shannon KM, Goetz CG, Pilgrim DM, Evans DA. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med. 1996 Jan 11; 334(2):71-6. PMID: 8531961.
      View in: PubMed
    335. Pappert EJ, Buhrfiend C, Lipton JW, Carvey PM, Stebbins GT, Goetz CG. Levodopa stability in solution: time course, environmental effects, and practical recommendations for clinical use. Mov Disord. 1996 Jan; 11(1):24-6. PMID: 8771063.
      View in: PubMed
    336. Goetz CG, Bonduelle M. Charcot as therapeutic interventionist and treating neurologist. Neurology. 1995 Nov; 45(11):2102-6. PMID: 7501168.
      View in: PubMed
    337. Hubble JP, Koller WC, Cutler NR, Sramek JJ, Friedman J, Goetz C, Ranhosky A, Korts D, Elvin A. Pramipexole in patients with early Parkinson's disease. Clin Neuropharmacol. 1995 Aug; 18(4):338-47. PMID: 8665547.
      View in: PubMed
    338. Pappert EJ, Goetz CG. Early American neurologic textbooks. Neurology. 1995 Jun; 45(6):1228-32. PMID: 7783901.
      View in: PubMed
    339. McDermott MP, Jankovic J, Carter J, Fahn S, Gauthier S, Goetz CG, Golbe LI, Koller W, Lang AE, Olanow CW, et al. Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group. Arch Neurol. 1995 Jun; 52(6):565-70. PMID: 7763203.
      View in: PubMed
    340. Goetz CG, Stebbins GT, Chmura TA, Fahn S, Klawans HL, Marsden CD. Teaching tape for the motor section of the unified Parkinson's disease rating scale. Mov Disord. 1995 May; 10(3):263-6. PMID: 7544438.
      View in: PubMed
    341. Goetz CG, Stebbins GT. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology. 1995 Apr; 45(4):669-71. PMID: 7723953.
      View in: PubMed
    342. Comella CL, Goetz CG. Akathisia in Parkinson's disease. Mov Disord. 1994 Sep; 9(5):545-9. PMID: 7990849.
      View in: PubMed
    343. Goetz C. [Charcot: a scientific Janus]. Rev Neurol (Paris). 1994 Aug-Sep; 150(8-9):485-9. PMID: 7754281.
      View in: PubMed
    344. Goetz CG, Stebbins GT, Shale HM, Lang AE, Chernik DA, Chmura TA, Ahlskog JE, Dorflinger EE. Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Mov Disord. 1994 Jul; 9(4):390-4. PMID: 7969204.
      View in: PubMed
    345. Goetz CG, Bolla KI, Rogers SM. Neurologic health outcomes and Agent Orange: Institute of Medicine report. Neurology. 1994 May; 44(5):801-9. PMID: 8190278.
      View in: PubMed
    346. Goetz CG, Stebbins GT, Thelen JA. Talipexole and adult Gilles de la Tourette's syndrome: double-blind, placebo-controlled clinical trial. Mov Disord. 1994 May; 9(3):315-7. PMID: 7913738.
      View in: PubMed
    347. Comella CL, Stebbins GT, Brown-Toms N, Goetz CG. Physical therapy and Parkinson's disease: a controlled clinical trial. Neurology. 1994 Mar; 44(3 Pt 1):376-8. PMID: 8145901.
      View in: PubMed
    348. Olanow CW, Marsden CD, Lang AE, Goetz CG. The role of surgery in Parkinson's disease management. Neurology. 1994 Mar; 44(3 Suppl 1):S17-20. PMID: 8121577.
      View in: PubMed
    349. Goetz CG, Penn RD, Klawans HL. Fetal-tissue transplantation for Parkinson's disease. N Engl J Med. 1993 Nov 11; 329(20):1498; author reply 1499-500. PMID: 8413464.
      View in: PubMed
    350. Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology. 1993 Nov; 43(11):2227-9. PMID: 8232934.
      View in: PubMed
    351. Kurth MC, Tetrud JW, Tanner CM, Irwin I, Stebbins GT, Goetz CG, Langston JW. Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations. Neurology. 1993 Sep; 43(9):1698-703. PMID: 8414015.
      View in: PubMed
    352. Samtleben W, Bauriedel G, Bosch T, Goetz C, Klare B, Gurland HJ. Renal complications of infected ventriculoatrial shunts. Artif Organs. 1993 Aug; 17(8):695-701. PMID: 8215950.
      View in: PubMed
    353. Buchman AS, Comella CL, Stebbins GT, Tanner CM, Goetz CG. Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia. Clin Neuropharmacol. 1993 Jun; 16(3):205-10. PMID: 8504437.
      View in: PubMed
    354. Goetz CG, Thelen JA, MacLeod CM, Carvey PM, Bartley EA, Stebbins GT. Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exercise. Neurology. 1993 May; 43(5):1040-2. PMID: 8492923.
      View in: PubMed
    355. Carvey PM, Ptak LR, Nath ST, Sierens DK, Mufson EJ, Goetz CG, Klawans HL. Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures. Exp Neurol. 1993 Mar; 120(1):149-52. PMID: 8097475.
      View in: PubMed
    356. Diederich NJ, Goetz CG. [Fetal and adrenal transplantation in Parkinson disease: theoretical bases and clinical results]. Bull Soc Sci Med Grand Duche Luxemb. 1993; 130(1):25-36. PMID: 8222013.
      View in: PubMed
    357. Goetz CG, De Long MR, Penn RD, Bakay RA. Neurosurgical horizons in Parkinson's disease. Neurology. 1993 Jan; 43(1):1-7. PMID: 8423869.
      View in: PubMed
    358. Wilson RS, Gilley DW, Tanner CM, Goetz CG. Ideational fluency in Parkinson's disease. Brain Cogn. 1992 Nov; 20(2):236-44. PMID: 1449756.
      View in: PubMed
    359. Goetz CG, Pappert EJ. Trauma and movement disorders. Neurol Clin. 1992 Nov; 10(4):907-19. PMID: 1435664.
      View in: PubMed
    360. Diederich N, Goetz CG, Stebbins GT, Klawans HL, Nittner K, Koulosakis A, Sanker P, Sturm V. Blinded evaluation confirms long-term asymmetric effect of unilateral thalamotomy or subthalamotomy on tremor in Parkinson's disease. Neurology. 1992 Jul; 42(7):1311-4. PMID: 1620340.
      View in: PubMed
    361. Goetz CG, Diederich NJ. Dopaminergic agonists in the treatment of Parkinson's disease. Neurol Clin. 1992 May; 10(2):527-40. PMID: 1350052.
      View in: PubMed
    362. Comella CL, Buchman AS, Tanner CM, Brown-Toms NC, Goetz CG. Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology. 1992 Apr; 42(4):878-82. PMID: 1565246.
      View in: PubMed
    363. Goetz CG, Tanner CM, Stebbins GT, Leipzig G, Carr WC. Adult tics in Gilles de la Tourette's syndrome: description and risk factors. Neurology. 1992 Apr; 42(4):784-8. PMID: 1565232.
      View in: PubMed
    364. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, Watts R. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord. 1992; 7(1):2-13. PMID: 1557062.
      View in: PubMed
    365. Goetz CG. Clonidine and clonazepam in Tourette syndrome. Adv Neurol. 1992; 58:245-51. PMID: 1414629.
      View in: PubMed
    366. Goetz CG, Stebbins GT, Klawans HL, Koller WC, Grossman RG, Bakay RA, Penn RD. United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical, and 1- and 2-year follow-up. Neurology. 1991 Nov; 41(11):1719-22. PMID: 1944898.
      View in: PubMed
    367. Carvey PM, Ptak LR, Lo ES, Lin DH, Buhrfiend CM, Goetz CG, Klawans HL. Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures. Exp Neurol. 1991 Oct; 114(1):28-34. PMID: 1915732.
      View in: PubMed
    368. Koller WC, Block GA, Ahlskog JE, Ahrens S, Cedarbaum JM, Cyhan G, Goetz CG, LeWitt PA, Liss C, McLean L, et al. Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter study. Clin Neuropharmacol. 1991 Aug; 14(4):322-9. PMID: 1913699.
      View in: PubMed
    369. Carvey PM, McRae A, Lint TF, Ptak LR, Lo ES, Goetz CG, Klawans HL. The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease. Neurology. 1991 May; 41(5 Suppl 2):53-8; discussion 59-60. PMID: 2041594.
      View in: PubMed
    370. Kordower JH, Cochran E, Penn RD, Goetz CG. Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease. Ann Neurol. 1991 Apr; 29(4):405-12. PMID: 1681779.
      View in: PubMed
    371. Goetz CG. Visual art in the neurologic career of Jean-Martin Charcot. Arch Neurol. 1991 Apr; 48(4):421-5. PMID: 2012518.
      View in: PubMed
    372. Shults CW, O'Connor DT, Baird A, Hill R, Goetz CG, Watts RL, Klawans HL, Carvey PM, Bakay RA, Gage FH, et al. Clinical improvement in parkinsonian patients undergoing adrenal to caudate transplantation is not reflected by chromogranin A or basic fibroblast growth factor in ventricular fluid. Exp Neurol. 1991 Mar; 111(3):276-81. PMID: 1999231.
      View in: PubMed
    373. Goetz CG, Stebbins GT. Effects of head trauma from motor vehicle accidents on Parkinson's disease. Ann Neurol. 1991 Feb; 29(2):191-3. PMID: 2012388.
      View in: PubMed
    374. Olanow CW, Koller W, Goetz CG, Stebbins GT, Cahill DW, Gauger LL, Morantz R, Penn RD, Tanner CM, Klawans HL, et al. Autologous transplantation of adrenal medulla in Parkinson's disease. 18-month results. Arch Neurol. 1990 Dec; 47(12):1286-9. PMID: 2252446.
      View in: PubMed
    375. Diederich N, Goetz CG, Comella CL. New approaches in the treatment of the dystonias. Klin Wochenschr. 1990 Oct 03; 68(19):935-41. PMID: 2232624.
      View in: PubMed
    376. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology. 1990 Oct; 40(10):1529-34. PMID: 2215943.
      View in: PubMed
    377. Goetz CG. Dopaminergic agonists in the treatment of Parkinson's disease. Neurology. 1990 Oct; 40(10 Suppl 3):suppl 50-4; discussion 54-7. PMID: 1977104.
      View in: PubMed
    378. Goetz CG, Tanner CM, Penn RD, Stebbins GT, Gilley DW, Shannon KM, Klawans HL, Comella CL, Wilson RS, Witt T. Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor data. Neurology. 1990 Feb; 40(2):273-6. PMID: 2300248.
      View in: PubMed
    379. Goetz CG, Stebbins GT, Klawans HL, Koller WC, Grossman RG, Bakay RA, Penn RD. United Parkinson Foundation Neurotransplantation Registry: multicenter US and Canadian data base, presurgical and 12 month follow-up. Prog Brain Res. 1990; 82:611-7. PMID: 2290962.
      View in: PubMed
    380. Goetz CG, Tanner CM. Gilles de la Tourette's syndrome in twins: clinical and neurochemical data. Mov Disord. 1990; 5(2):173-5. PMID: 1691443.
      View in: PubMed
    381. Dietz MA, Goetz CG, Stebbins GT. Evaluation of a modified inverted walking stick as a treatment for parkinsonian freezing episodes. Mov Disord. 1990; 5(3):243-7. PMID: 2388642.
      View in: PubMed
    382. Carvey PM, McRae A, Ptak LR, Kao LC, Lo ES, Goetz CG, Tanner CM, Penn RD, Klawans HL. Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor. Prog Brain Res. 1990; 82:693-7. PMID: 2290972.
      View in: PubMed
    383. Goetz CG, Tanner CM, Gilley DW, Klawans HL. Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa. Neurology. 1989 Nov; 39(11 Suppl 2):63-6; discussion 72-3. PMID: 2586764.
      View in: PubMed
    384. Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol. 1989 Oct; 12(5):375-83. PMID: 2575449.
      View in: PubMed
    385. Fox JH, Bennett DA, Goetz CG, Penn RD, Savoy S, Clasen R, Wilson RS. Induction of parkinsonism by intraventricular bethanechol in a patient with Alzheimer's disease. Neurology. 1989 Sep; 39(9):1265. PMID: 2570380.
      View in: PubMed
    386. Bennett DA, Ristanovic RK, Morrell F, Goetz CG. Dystonic posturing in temporal lobe seizures. Neurology. 1989 Sep; 39(9):1270-2. PMID: 2590310.
      View in: PubMed
    387. Goetz CG, Shannon KM, Tanner CM, Carroll VS, Klawans HL. Agonist substitution in advanced Parkinson's disease. Neurology. 1989 Aug; 39(8):1121-2. PMID: 2761708.
      View in: PubMed
    388. Tanner CM, Chen B, Wang W, Peng M, Liu Z, Liang X, Kao LC, Gilley DW, Goetz CG, Schoenberg BS. Environmental factors and Parkinson's disease: a case-control study in China. Neurology. 1989 May; 39(5):660-4. PMID: 2710356.
      View in: PubMed
    389. Goetz CG, Olanow CW, Koller WC, Penn RD, Cahill D, Morantz R, Stebbins G, Tanner CM, Klawans HL, Shannon KM. Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med. 1989 Feb 09; 320(6):337-41. PMID: 2643770.
      View in: PubMed
    390. Goetz CG, Tanner CM, Stebbins GT, Buchman AS. Risk factors for progression in Parkinson's disease. Neurology. 1988 Dec; 38(12):1841-4. PMID: 3194061.
      View in: PubMed
    391. McRae-Degueurce A, Klawans HL, Penn RD, Dahlstrom A, Tanner CM, Goetz CG, Carvey PM. An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation. Neurosci Lett. 1988 Nov 22; 94(1-2):192-7. PMID: 3241668.
      View in: PubMed
    392. Sprague SM, Corwin HL, Tanner CM, Wilson RS, Green BJ, Goetz CG. Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients. Arch Intern Med. 1988 Oct; 148(10):2169-72. PMID: 3178374.
      View in: PubMed
    393. Goetz CG. Shakespeare in Charcot's neurologic teaching. Arch Neurol. 1988 Aug; 45(8):920-1. PMID: 3293556.
      View in: PubMed
    394. Goetz CG, Tanner CM, Shannon KM, Carroll VS, Klawans HL, Carvey PM, Gilley D. Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations. Neurology. 1988 Jul; 38(7):1143-6. PMID: 3290706.
      View in: PubMed
    395. Penn RD, Goetz CG, Tanner CM, Klawans HL, Shannon KM, Comella CL, Witt TR. The adrenal medullary transplant operation for Parkinson's disease: clinical observations in five patients. Neurosurgery. 1988 Jun; 22(6 Pt 1):999-1004. PMID: 3419583.
      View in: PubMed
    396. Buchman AS, Goetz CG, Klawans HL. Hemiparkinsonism with hemiatrophy. Neurology. 1988 Apr; 38(4):527-30. PMID: 3352904.
      View in: PubMed
    397. Goetz CG. The Salpêtrière in the wake of Charcot's death. Arch Neurol. 1988 Apr; 45(4):444-7. PMID: 3281638.
      View in: PubMed
    398. Klawans HL, Tanner CM, Goetz CG. Epidemiology and pathophysiology of tardive dyskinesias. Adv Neurol. 1988; 49:185-97. PMID: 2894124.
      View in: PubMed
    399. Goetz CG, Penn RD, Tanner CM. Efficacy of cervical cord stimulation in dystonia. Adv Neurol. 1988; 50:645-9. PMID: 3261120.
      View in: PubMed
    400. Tanner CM, Wilson RS, Goetz CG, Shannon KM. The predictive value of acute antimuscarinic drugs for the chronic efficacy of antimuscarinic drugs in adults with focal dystonia. Adv Neurol. 1988; 50:557-60. PMID: 3400510.
      View in: PubMed
    401. Carvey PM, Hitri A, Goetz CG, Tanner CM, Klawans HL. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation. Life Sci. 1988; 42(22):2207-15. PMID: 3374255.
      View in: PubMed
    402. Jankovic J, Armstrong D, Low NL, Goetz CG. Case 2, 1988. Congenital mental retardation and juvenile parkinsonism. Mov Disord. 1988; 3(4):352-61. PMID: 3211183.
      View in: PubMed
    403. Shannon KM, Goetz CG, Carroll VS, Tanner CM, Klawans HL. Amantadine and motor fluctuations in chronic Parkinson's disease. Clin Neuropharmacol. 1987 Dec; 10(6):522-6. PMID: 3427558.
      View in: PubMed
    404. Goetz CG, Tanner CM, Wilson RS, Shannon KM. A rating scale for Gilles de la Tourette's syndrome: description, reliability, and validity data. Neurology. 1987 Sep; 37(9):1542-4. PMID: 3476860.
      View in: PubMed
    405. Goetz CG, Tanner CM, Carroll VS, Shannon KM, Klawans HL. Controlled-release Sinemet. Neurology. 1987 Sep; 37(9):1567-8. PMID: 3627466.
      View in: PubMed
    406. Goetz CG. Charcot at the Salpêtrière: ambulatory automatisms. Neurology. 1987 Jun; 37(6):1084-8. PMID: 3295588.
      View in: PubMed
    407. Buchman AS, Bennett DA, Goetz CG. Bromocriptine-induced myoclonus. Neurology. 1987 May; 37(5):885. PMID: 3574698.
      View in: PubMed
    408. Goetz CG, Tanner CM, Klawans HL, Shannon KM, Carroll VS. Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet). Neurology. 1987 May; 37(5):875-8. PMID: 3574696.
      View in: PubMed
    409. Goetz CG, Tanner CM, Shannon KM. Progression of Parkinson's disease without levodopa. Neurology. 1987 Apr; 37(4):695-8. PMID: 3561783.
      View in: PubMed
    410. Goetz CG, Tanner CM, Wilson RS, Carroll VS, Como PG, Shannon KM. Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods. Ann Neurol. 1987 Mar; 21(3):307-10. PMID: 3300518.
      View in: PubMed
    411. Tanner CM, Goetz CG, Glantz RH, Klawans HL. Pergolide mesylate: four years experience in Parkinson's disease. Adv Neurol. 1987; 45:547-9. PMID: 3825732.
      View in: PubMed
    412. Goetz CG, Shannon KM, Carroll VS, Tanner CM, Weingarten R. The autonomic nervous system in Gilles de la Tourette's syndrome. Mov Disord. 1987; 2(2):99-102. PMID: 2904121.
      View in: PubMed
    413. Goetz CG, Wilson RS, Tanner CM, Garron DC. Relationships among pain, depression, and sleep alterations in Parkinson's disease. Adv Neurol. 1987; 45:345-7. PMID: 3825708.
      View in: PubMed
    414. Klawans HL, Carvey PM, Nelson D, Tanner CM, Goetz CG. The effect of thioridazine on haloperidol induced behavioral hypersensitivity. Life Sci. 1986 May 12; 38(19):1707-14. PMID: 3702600.
      View in: PubMed
    415. Carvey PM, Kao LC, Tanner CM, Goetz CG, Klawans HL. The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivity. Eur J Pharmacol. 1986 Jan 21; 120(2):193-9. PMID: 3948919.
      View in: PubMed
    416. Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC. Pain in Parkinson's disease. Mov Disord. 1986; 1(1):45-9. PMID: 3504231.
      View in: PubMed
    417. Carvey P, Paulseth JE, Goetz CG, Klawans HL. L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update. Adv Neurol. 1986; 43:509-17. PMID: 3484857.
      View in: PubMed
    418. Goetz CG, Lutge W, Tanner CM. Autonomic dysfunction in Parkinson's disease. Neurology. 1986 Jan; 36(1):73-5. PMID: 3941786.
      View in: PubMed
    419. Goetz CG. Charcot on Parkinson's disease. Mov Disord. 1986; 1(1):27-32. PMID: 3332804.
      View in: PubMed
    420. Klawans HL, Carvey PM, Tanner CM, Goetz CG. Drug-induced myoclonus. Adv Neurol. 1986; 43:251-64. PMID: 3484854.
      View in: PubMed
    421. Tanner CM, Chhablani R, Goetz CG, Klawans HL. Pergolide mesylate: lack of cardiac toxicity in patients with cardiac disease. Neurology. 1985 Jun; 35(6):918-21. PMID: 3889707.
      View in: PubMed
    422. Goetz CG, Tanner CM, Glantz RH, Klawans HL. Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide. Neurology. 1985 May; 35(5):749-51. PMID: 3990974.
      View in: PubMed
    423. Klawans HL, Carvey P, Tanner CM, Goetz CG. The pathophysiology of tardive dyskinesia. J Clin Psychiatry. 1985 Apr; 46(4 Pt 2):38-41. PMID: 2858479.
      View in: PubMed
    424. Goetz CG, Tanner CM, Klawans HL. Bupropion in Parkinson's disease. Neurology. 1984 Aug; 34(8):1092-4. PMID: 6431314.
      View in: PubMed
    425. Goetz CG, Carvey PM, Tanner CM, Klawans HL. Neuroleptic-induced dopamine hyposensitivity. Life Sci. 1984 Apr 09; 34(15):1475-9. PMID: 6538629.
      View in: PubMed
    426. Goetz CG, Tanner CM, Klawans HL. Fluphenazine and multifocal tic disorders. Arch Neurol. 1984 Mar; 41(3):271-2. PMID: 6582810.
      View in: PubMed
    427. Gerratt BR, Goetz CG, Fisher HB. Speech abnormalities in tardive dyskinesia. Arch Neurol. 1984 Mar; 41(3):273-6. PMID: 6696646.
      View in: PubMed
    428. Goetz CG. Sinemet skin rash. Clin Neuropharmacol. 1984; 7(1):107-8. PMID: 6231101.
      View in: PubMed
    429. Goetz CG, Tanner CM, Klawans HL. The pharmacology of olivopontocerebellar atrophy. Adv Neurol. 1984; 41:143-8. PMID: 6496225.
      View in: PubMed
    430. Goetz CG. Skin rash associated with Sinemet 25/100. N Engl J Med. 1983 Dec 01; 309(22):1387-8. PMID: 6226874.
      View in: PubMed
    431. Goetz CG, Tanner CM, Glantz R, Klawans HL. Pergolide in Parkinson's disease. Arch Neurol. 1983 Dec; 40(13):785-7. PMID: 6639407.
      View in: PubMed
    432. Goetz CG, Klawans HL. On the mechanism of sudden death in Moersch-Woltman syndrome. Neurology. 1983 Jul; 33(7):930-2. PMID: 6683379.
      View in: PubMed
    433. Klawans HL, Goetz CG, Carvey P. Animal models of tardive dyskinesias. Clin Neuropharmacol. 1983 Jun; 6(2):129-35. PMID: 6133617.
      View in: PubMed
    434. Goetz CG. Drug-induced Parkinsonism and idiopathic Parkinson's disease. Arch Neurol. 1983 May; 40(5):325-6. PMID: 6133514.
      View in: PubMed
    435. Klawans HL, Tanner CM, Glatt S, Goetz CG. A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease. Adv Neurol. 1983; 37:75-83. PMID: 6344592.
      View in: PubMed
    436. Klawans HL, Goetz CG, Tanner CM, Nausieda PA, Weiner WJ. Levodopa-free periods ("drug holidays") in the management of parkinsonism. Adv Neurol. 1983; 37:33-43. PMID: 6858778.
      View in: PubMed
    437. Goetz CG, Klawans HL, Carvey P. Animal models of tardive dyskinesia: their use in the search for new treatment methods. Mod Probl Pharmacopsychiatry. 1983; 21:5-20. PMID: 6140633.
      View in: PubMed
    438. Goetz CG, Tanner CM, Klawans HL. Drug holiday in the management of Parkinson disease. Clin Neuropharmacol. 1982 Dec; 5(4):351-64. PMID: 6760963.
      View in: PubMed
    439. Tanner CM, Goetz CG, Klawans HL. Cholinergic mechanisms in Tourette syndrome. Neurology. 1982 Nov; 32(11):1315-7. PMID: 6957735.
      View in: PubMed
    440. Tanner CM, Goetz CG, Glantz RH, Glatt SL, Klawans HL. Pergolide mesylate and idiopathic Parkinson disease. Neurology. 1982 Oct; 32(10):1175-9. PMID: 6889702.
      View in: PubMed
    441. Klawans HL, Stein RW, Tanner CM, Goetz CG. A pure parkinsonian syndrome following acute carbon monoxide intoxication. Arch Neurol. 1982 May; 39(5):302-4. PMID: 7073551.
      View in: PubMed
    442. Glantz R, Weiner WJ, Goetz CG, Nausieda PA, Klawans HL. Drug-induced asterixis in Parkinson disease. Neurology. 1982 May; 32(5):553-5. PMID: 7200212.
      View in: PubMed
    443. Goetz CG, Tanner CM, Klawans HL. Pharmacology of hallucinations induced by long-term drug therapy. Am J Psychiatry. 1982 Apr; 139(4):494-7. PMID: 6802003.
      View in: PubMed
    444. Klawans HL, Glantz R, Tanner CM, Goetz CG. Primary writing tremor: a selective action tremor. Neurology. 1982 Feb; 32(2):203-6. PMID: 7198747.
      View in: PubMed
    445. Goetz CG, Klawans HL. Gilles de la Tourette on Tourette syndrome. Adv Neurol. 1982; 35:1-16. PMID: 6756085.
      View in: PubMed
    446. Weiner WJ, Carvey P, Nausieda PA, Goetz CG, Klawans HL. Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig. Adv Neurol. 1982; 35:213-9. PMID: 6890754.
      View in: PubMed
    447. Goetz CG, Tanner CM, Klawans HL. Compressive neuropathies in Tourette syndrome. Adv Neurol. 1982; 35:345-7. PMID: 6959511.
      View in: PubMed
    448. Goetz CG, Tanner CM, Nausieda PA. Weekly drug holiday in Parkinson disease. Neurology. 1981 Nov; 31(11):1460-2. PMID: 7031503.
      View in: PubMed
    449. Goetz CG, Klawans HL. Drug-induced extrapyramidal disorders - a neuropsychiatric interface. J Clin Psychopharmacol. 1981 Sep; 1(5):297-303. PMID: 6120959.
      View in: PubMed
    450. Tanner CM, Goetz CG. CPK values in Parkinson's disease. N Engl J Med. 1981 Jun 25; 304(26):1608-9. PMID: 7231513.
      View in: PubMed
    451. Weiner WJ, Carvey P, Nausieda PA, Goetz CG, Klawans HL. The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig. Life Sci. 1981 May 11; 28(19):2173-8. PMID: 7195969.
      View in: PubMed
    452. Goetz CG, Nausieda PA, Weiner WJ, Klawans HL. Practical guidelines for drug holidays in parkinsonian patients. Neurology. 1981 May; 31(5):641-2. PMID: 7194987.
      View in: PubMed
    453. Koller WC, Weiner WJ, Perlik S, Nausieda PA, Goetz CG, Klawans HL. Complications of chronic levodopa therapy: long-term efficacy of drug holiday. Neurology. 1981 Apr; 31(4):473-6. PMID: 7194441.
      View in: PubMed
    454. Glantz R, Goetz CG, Nausieda PA, Weiner WJ, Klawans HL. The effect of bromocriptine (BCT) on the on-off phenomenon. J Neural Transm. 1981; 52(1-2):41-7. PMID: 7026735.
      View in: PubMed
    455. Tanner C, Goetz CG, Weiner WJ. Anticholinergics and tardive dyskinesia. Am J Psychiatry. 1980 Nov; 137(11):1470-1. PMID: 6108080.
      View in: PubMed
    456. Goetz CG, Klawans HL. Gilles de la Tourette syndrome and compressive neuropathies. Ann Neurol. 1980 Oct; 8(4):453. PMID: 6933884.
      View in: PubMed
    457. Klawans HL, Goetz CG, Perlik S. Presymptomatic and early detection in Huntington's disease. Ann Neurol. 1980 Oct; 8(4):343-7. PMID: 6449173.
      View in: PubMed
    458. Klawans HL, Goetz CG, Perlik S. Tardive dyskinesia: review and update. Am J Psychiatry. 1980 Aug; 137(8):900-8. PMID: 6106395.
      View in: PubMed
    459. Goetz CG, Klawans HL. Chronic agonist-induced hypersensitivity and on-off hyperkinesis. Ann Neurol. 1979 Sep; 6(3):277-8. PMID: 534431.
      View in: PubMed
    460. Weiner WJ, Goetz CG, Nausieda PA, Klawans HL. Amphetamine-induced hypersensitivity in guinea pigs. Neurology. 1979 Jul; 29(7):1054-7. PMID: 572936.
      View in: PubMed
    461. Klawans HL, Goetz CG, Volkman P, Nausieda PA, Weiner WJ. Lergotrile in the treatment of parkinsonism. Neurology. 1978 Jul; 28(7):699-702. PMID: 566868.
      View in: PubMed
    462. Weiner WJ, Goetz CG, Nausieda PA, Klawans HL. Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea. Ann Intern Med. 1978 Mar; 88(3):327-31. PMID: 629494.
      View in: PubMed
    463. Weiner WJ, Goetz C, Nausleda PA, Klawans HL. Clonazepam and dopamine-related stereotyped behavior. Life Sci. 1977 Oct 01; 21(7):901-6. PMID: 562960.
      View in: PubMed
    464. Klawans HL, Goetz C, Nausieda PA, Weiner WJ. Levodopa-induced dopamine receptor hypersensitivity. Trans Am Neurol Assoc. 1977; 102:80-3. PMID: 616121.
      View in: PubMed
    465. Klawans HL, Goetz C, Nausieda PA, Weiner WJ. Recent advances in the biochemical pharmacology of extrapyramidal movement disorders. Adv Exp Med Biol. 1977; 90:21-47. PMID: 145167.
      View in: PubMed
    466. Klawans HL, Goetz C, Bergen D. Levodopa-induced myoclonus. Arch Neurol. 1975 May; 32(5):330-4. PMID: 1079721.
      View in: PubMed
    467. Klawans HL, Goetz C, Weiner WJ. Dopamine receptor site sensitivity in hyperthyroid and hypothyroid guinea pigs. Adv Neurol. 1974; 5:495-500. PMID: 4474797.
      View in: PubMed
    468. Klawans HL, Goetz C, Weiner WJ. 5-Hydroxytryptophan-induced myoclonus in guinea pigs and the possible role of serotonin in infantile myoclonus. Neurology. 1973 Nov; 23(11):1234-40. PMID: 4147723.
      View in: PubMed
    Goetz's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description